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ABSTRACT 
 
 
In South Africa, Salmonella Enteritidis has become a significant pathogen and the 
numbers of cases reported to the Centre for Enteric Diseases (CED) have increased. 
Pulsed-field gel electrophoresis (PFGE) is a primary for molecular subtyping of 
Salmonella. However, this technique has poor discrimination for serotypes with high 
homogeneity such as Salmonella Enteritidis. Multi-locus variable-number tandem-
repeats analysis (MLVA) has shown higher discriminatory power for Salmonella 
Enteritidis compared to PFGE. In this study, MLVA was used to investigate the 
molecular epidemiology and relatedness of human Salmonella Enteritidis strains from 
Gauteng and Western Cape, South Africa. Furthermore, MLVA was also used to 
investigate the relatedness of human and non-human Salmonella Enteritidis strains. 
MLVA included analysis of five VNTR loci, with varying degrees of diversity. A total of 
1221 human isolates and 43 non-human isolates were included in the study. Eighty-
six MLVA profiles were obtained; MLVA profiles 7, 21, 22 and 28 were the 
predominant MLVA profiles. MLVA profile 28 was the most common MLVA profile 
amongst both the human and non-human isolates. Isolates had low prevalence of 
antimicrobial resistance, however sulfamethoxazole resistance was notable amongst 
both the human (348; 29%) and non-human (10; 23%) isolates. During the study 
period, seven Salmonella Enteritidis outbreaks were investigated from six provinces 
and isolates from each individual outbreak showed an identical MLVA profile. MLVA 
was shown to be a successful molecular subtyping tool for Salmonella Enteritidis, for 
both surveillance purposes and outbreak investigations. Salmonella Enteritidis strains 
circulating within the human and non-human population were clonal. The study 
emphasizes the need for the one health approach, in order to curb the spread of 
Salmonella Enteritidis in South Africa.  
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CHAPTER 1: LITERATURE REVIEW 
 
1.1 Introduction 
 
Salmonella is a major cause of morbidity and mortality in children under the age of 
five in most developing countries worldwide (Kirk et al., 2015). The global human 
health impact of nontyphoidal Salmonella is high, with an estimated 93.8 million 
illnesses, of which 80.3 million are reported to be foodborne related, and 155,000 
deaths each year (Majowicz et al., 2010). Human illness caused by Salmonella 
enterica serovar Enteritidis (Salmonella Enteritidis) has drastically increased 
worldwide and by the 1980’s Salmonella Enteritidis had replaced Salmonella 
Typhimurium as the primary cause of salmonellosis globally (Rodrigue et al., 1990; 
Bern et al., 1992; Kosek et al., 2003). In Africa, the burden of Salmonella Enteritidis 
has not been established. However, it is estimated that Salmonella Enteritidis 
accounts for 33.1% of the total invasive non-typhoidal Salmonella (iNTS) infections 
(Ao et al., 2015).   
 
Since 2011, Salmonella Enteritidis has overtaken Salmonella Typhimurium as the 
most commonly reported Salmonella serotype to the Centre for Enteric Diseases 
(CED) at the National Institute for Communicable Diseases (NICD) in South Africa. 
Since then, the numbers of Salmonella Enteritidis cases have continued to increase 
(GERMS - SA Annual Report, 2012). 
 
Despite global efforts to curb its spread Salmonella Enteritidis infections persist, 
causing an on-going challenge to the global health system.  
 
 
1.2 History 
 
The genus Salmonella was accidentally discovered by Theobald Smith, during his 
quest to identify the causative agent of hog cholera in 1885. Although it was later 
discovered that a virus was the actual causative agent of hog cholera, the discovery 
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of Salmonella was of major importance and significance to microbiology (Meštrović, 
2015). 
 
 
1.3 Bacterial structure and characterization 
 
Salmonella is a rod-shaped Gram-negative bacterium, belonging to the 
Enterobacteriaceae family.  This facultative anaerobic, peritrichous flagella (flagella 
around entire surface) containing microorganism is highly motile and non-spore 
forming, with a diameter of about 0.7 μm to 1.5 μm and length between 2 μm and 5 
μm (Richard, 2008). 
 
Salmonella has 3 different types of antigens (O somatic, H flagellar and Vi capsular 
antigens) and the ability for these antigens to agglutinate with serum antibodies, 
enables them to be used serologically in the identification of over 2500 Salmonella 
serotypes (Gianella, 1996; Dutta et al., 2012). 
 
Salmonella is divided into two species: Salmonella bongori and Salmonella enterica, 
with the former being further classified into six subspecies (enterica, salamae, 
arizonae, diarizonae, houtenae, and indica) and a large number of serovars. 
Salmonella enterica subspecies 1 (enterica) consists of the most common O-antigen 
serogroups (A, B, C1, C2, D and E), which harbour strains that make up 99% of all 
Salmonella infections (Achtman et al., 2012).  
 
Salmonella enterica subspecies 1 can be divided into two groups; typhoidal and 
nontyphoidal Salmonella (NTS) serovars. NTS serovars such as Salmonella 
Typhimurium and Salmonella Enteritidis are the most common cause of 
salmonellosis globally (Tennant et al., 2016). These serovars commonly cause 
disease in both humans and animals (zoonotic) and illness is usually a mild, self-
limiting gastrointestinal disease. Typhoidal Salmonella serovars such as Salmonella 
Typhi and Salmonella Paratyphi A are adapted to human infection and therefore are 
not commonly found in other animals (Uzzau et al., 2000; Gal-Mor et al., 2014). 
Serovars present in the other subspecies (salamae, arizonae, diarizonae, houtenae, 
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and indica) are commonly found in cold-blooded animals and the environment; they 
are rarely isolated from humans (Uzzau et al., 2000). 
 
 
1.4 Epidemiology of Salmonella Enteritidis 
 
1.4.1 Global prevalence  
 
Salmonella has been well documented as the leading bacterial cause of acute 
gastroenteritis globally (Majowicz et al., 2010). Gastroenteritis is a major cause of 
morbidity and mortality worldwide, both in children <5 years old and in the general 
population as a whole. Despite these reports, there is still a lack of data describing 
the precise global impact of Salmonella infections to human health (Kirk et al., 2015).  
 
With an estimated 2.8 billion cases of diarrhoeal illness worldwide, Salmonella 
infections represent ∼3% of these illnesses (Majowicz et al., 2010). Thus, indicating 
the importance of this pathogen to human health (Scallan et al., 2005).  
 
In a web-based surveillance conducted by Galanis et al., (2006) from years 2002-
2003, Salmonella Enteritidis was the most common serotype reported from human 
isolates globally. In 2002, it accounted for 65% of all isolates, followed by Salmonella 
Typhimurium (12%) and Salmonella Newport (4%) respectively. In animals, 
Salmonella Enteritidis was the third most common serotype accounting for 9% of the 
isolates preceded by Salmonella Typhimurium and Salmonella Heidelberg (Galanis 
et al., 2006). 
 
1.4.2 Prevalence in developed countries 
 
In most developed countries, the numbers of Salmonella infection cases continue to 
increase and Salmonella Enteritidis has become the most commonly isolated 
Salmonella serotype in these countries (Ao et al., 2015).  
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In the United States of America (USA), the annual incidence of Salmonella Enteritidis 
infection remained relatively steady from 1996-2003, with an incidence rate of 
1.9/100,000 population. However in 2008, the incidence rate steadily increased to a 
maximum of 2.8/100,000 population, which was representative of a 44% increase 
since the period 1996-1999 (Chai et al., 2012). During the years 2004 to 2009, 6777 
Salmonella Enteritidis infections had been reported in the USA, the most affected 
age group was the <4 years old, with an incidence rate of 4.7/100,000 to 6.9/100,000 
population (Chai et al., 2012). In 2011, the Centers for Disease Control and 
Prevention (CDC) reported Salmonella Enteritidis as the most common serotype 
accounting for 22%, followed by Salmonella Newport (14%), and Salmonella 
Typhimurium (13%). 
 
In Canada, over 10 000 laboratory confirmed cases of Salmonella Enteritidis were 
reported between the years 2003-2009. The incidence rate was shown to have 
increased from 2.16/100,000 population in 2003 to 5.79/100,000 population in 2009 
(63% increase). Of all reported cases of Salmonella, the proportion of Salmonella 
Enteritidis isolates rose from 12.7% in 2003 to 32.1% in 2009 (Nesbitt et al., 2012). 
 
Salmonella Enteritidis is the most common Salmonella serovar and a major cause of 
outbreaks in Europe (European Food Safety Authority, 2014). Surveillance data 
collected from 23 European countries between the years 2006-2007 showed that 
Salmonella Enteritidis was the most common serovar isolated from humans 
(European Food Safety Authority, 2009). Between the years 2007 to 2013, 328 537 
Salmonella Enteritidis cases were reported to the European Surveillance System 
(TESSy) by 27 countries, with Germany and the Czech Republic together accounting 
for 52% of all cases. The age group most affected were those <15 years of age, 
accounting for 43% (n = 139,090). In 2012, Salmonella Enteritidis accounted for 179 
outbreaks in Europe, this making up 37% of all Salmonella outbreaks that year 
(European Food Safety Authority, 2014). 
 
Asia has one of the highest incidences of Salmonella infection cases in the world, 
with 32-cases/100,000 population in high income areas of the Asia Pacific region to 
3,600/100,000 population in Southeast Asia (McKeown et al., 2012). In Asia, 
Salmonella Enteritidis has emerged as the most common human isolated Salmonella 
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serotype in countries like Japan, the Republic of Korea and Thailand (Ng et al, 1997; 
Galanis et al., 2006). In Singapore, Salmonella Enteritidis accounted for 62.2% of the 
human non-typhoidal salmonellosis in 2007 (Ministry of Health Singapore, 2007). 
 
1.4.3 Prevalence in Africa  
 
In developed countries most Salmonella infections are often associated with 
gastroenteritis and have case-fatality rates of <1% (Varma et al., 2005; Feasey et al., 
2012). However in Africa, NTS is a major concern because of the Human 
Immunodeficiency Virus (HIV) and malaria epidemic (Graham et al., 2000a; 
Galanakis et al., 2007). People with such illnesses are immune-compromised and 
research has shown that NTS is one of the most common causes for hospital 
admissions in such immune compromised people (Graham et al., 2000a; Graham, 
2002). Despite the increased prevalence of HIV and malaria, most African countries 
are unable to provide clean water and proper sanitation to the communities. Such 
limitations play a major role in the continual increase of NTS morbidity and mortality, 
particularly in young children (Berkley et al., 2005; Enwere et al., 2006; Bessong et 
al., 2009). 
 
In Sub-Saharan Africa, NTS is among the top three most common pathogens 
responsible for bacterial bloodstream infections in both adults and young children 
(Shaw et al., 2008; Sigauque et al., 2009). Young children under three years of age 
as well as adults infected with HIV carry most of the burden of invasive disease and 
mortality within these two groups is high (Morpeth et al., 2009). Furthermore, several 
studies have described the association of NTS infection and malaria infection, 
particularly amongst young children in malaria endemic countries (Morpeth et al., 
2009; Takem et al., 2014). Studies conducted in Sub-Saharan Africa have shown 
that there seems to be an increased risk of invasive NTS amongst children with 
malaria and mortality associated with co-infection seems higher than that associated 
with malaria alone (Takem et al., 2014). Sadly, majority of these studies do not 
further characterise the NTS to serotype level.  
 
Due to limited data from most African countries, the total burden of Salmonella 
Enteritidis in Africa has not been established. However, few studies have described 
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Salmonella Enteritidis as one of the major causes of iNTS in Africa (Feasey et al., 
2012). A study by Ao et al. (2015) estimated that Salmonella Enteritidis accounts for 
33.1% of the total burden of iNTS in Africa. In South Africa, between the years 2003 
and 2004, Salmonella Enteritidis accounted for 10% of the iNTS cases (Feasey et al., 
2010). However, poor reporting and poor surveillance in most African countries make 
estimation of burden of disease a challenge. 
 
1.4.4 Prevalence in South Africa 
 
In South Africa, the CED at the NICD initiated laboratory-based surveillance of 
enteric bacteria for public health importance in 2003 and this was primarily in 
response to the HIV epidemic in the country. During this time, the predominant 
Salmonella serotypes were Salmonella Typhimurium and Salmonella Isangi (Feasey 
et al., 2010; Feasey et al, 2012). The introduction of highly active antiretroviral 
therapy (HAART) in 2004, showed a gradual decline in invasive salmonellosis, more 
especially in those serotypes that were associated with HIV infection such as 
Salmonella Typhimurium, whose association with HIV in Africa has been extensively 
described (Keddy et al., 2009). However since 2011, Salmonella Enteritidis has 
become a more important pathogen and the numbers of cases reported to the CED 
have increased (Figure 1.1). This increase is still unexplained and it is independent of 
the HIV epidemic in the country (GERMS - SA Annual Report, 2012). 
  
Figure 1.1. Bar graph illustrating the gradual increase of Salmonella Enteritidis 
isolates received at the CED from the year 2003.      
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1.4.5 Risk factors for Salmonella infection 
 
1.4.5.1 Age as a risk factor 
 
Globally, Salmonella incidence rates amongst the different age groups produces a 
bimodal distribution, with the first peak observed in children (<5 years) and the 
second observed in the elderly age group (WHO and FAO, 2002). However in Africa, 
a different bimodal distribution is described; this bimodal distribution has its initial 
peak in the <5 age group and the second peak occurring in the adult age groups (Ao 
et al., 2015).  
 
Plausible risk factors amongst the different age groups include the lack of a fully 
developed immune system (young children), poor hygiene, a weakened immune 
system due to diseases and age-related decreased immune function (WHO and FAO, 
2002). 
 
1.4.5.2 Sex as a risk factor 
 
Generally, Salmonella infections seem to infect both males and females equally. 
However, factors such as lifestyle (behavioural) may make another gender more 
prone to infection the other. Thus, sex as a risk factor for Salmonella infection 
remains a highly debatable subject (WHO and FAO, 2002). 
 
 
1.4.6 Surveillance  
 
Improvements are required on the estimation of the burden disease for pathogens 
such as Salmonella. These improvements would ensure that countries effectively 
design appropriate public health goals and allocate adequate resources to reduce 
disease burden (Senior, 2009). 
 
 Although laboratory-based surveillance provides useful trend information, it however 
does not give a true reflection of what is occurring in society, in terms of disease 
burden (underestimates disease burden) (Flint et al., 2005). In order to be certain 
that a laboratory-based surveillance system is an effective type of surveillance, every 
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ill person that seeks medical attention would have to submit a specimen. The 
laboratory would have to test for the pathogen and report a positive result and public 
health authorities would have to ascertain the laboratory-confirmed infection 
(Wheeler et al., 1999; Hall et al., 2005). However, even with such a system in place, 
not all countries are able to carry out such surveillance and compile such extensive 
data due to the financial constraints (laboratory based surveillances can be 
expensive); therefore making global estimates of disease burden difficult to calculate 
(Majowicz et al., 2010). Nonetheless, it is evident that Salmonella infections are a 
global challenge and despite limited data on the precise global incidence rate, small 
surveillance programmes from many parts of the world show the need for continual 
monitoring of Salmonella infections (Scallan et al., 2005; Majowicz et al., 2010; Kirk 
et al., 2015). 
 
 
1.5 Transmission  
                                                                                                                                                                                                        
Humans are the main reservoirs for typhoidal Salmonella. However, farm animals 
(chicken, cows, pigs and sheep) are the main reservoirs for human NTS infections. 
Other reservoirs include wild and domestic animals, as wells as reptiles (Mangni and 
Arvntikis, 2010).  
 
Poultry and poultry products have been extensively described as the main source of 
Salmonella Enteritidis infection. In countries with increased occurrences of 
Salmonella outbreaks, it has been reported that 50-90% of all poultry related cases 
have been infected by Salmonella Enteritidis. Furthermore, in most outbreak 
investigations, eggs have been extensively described as the main reservoir for 
Salmonella Enteritidis infection in the poultry farming industry (Andino and Hanning, 
2015). 
 
Egg contamination by Salmonella serotypes has always been a major problem and 
this has been mainly attributed to the use of eggs with outer-shell contamination 
(environmental contamination factors) (Gianella, 1996; Mangni and Arvntikis, 2010). 
However, unlike most other Salmonella serotypes, Salmonella Enteritidis is able to 
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pass through the hard egg exterior and infect the egg internally.  The pathogenic 
mechanisms involved in this occurrence are complex and are currently not fully 
understood. Furthermore, it seems that Salmonella Enteritidis has gained 
mechanisms that enable it to survive and grow in the internal egg contents more 
efficiently compared to the other serotypes (Gantois et al., 2009). Salmonella 
Enteritidis has the ability to infect an egg through the transovarian route and during 
intestinal carriage. This allows Salmonella Enteritidis to infect both the internal and 
external parts of the egg, and when eggs are stored at room temperature the number 
of bacterial cells in the egg increases and hence increasing the infectivity (Gantois et 
al., 2009).  
 
Other modes of Salmonella Enteritidis infection include the consumption of 
vegetables, products such as peanut butter and milk. Other rare methods of 
transmission include drinking contaminated water and person-person spread 
(Gianella, 1996; Mangni and Arvntikis, 2010). 
 
Although Salmonella Enteritidis infections are common in most populations globally, 
human asymptomatic carriage and spread is not common. However, asymptomatic 
carriage by chickens, birds and other animals such as mice has been reported 
(Davies and Wray, 1995; Hoelzer et al., 2011).  
 
 
1.6 Clinical features  
 
The most common manifestation of Salmonella Enteritidis is the gastroenteritis 
syndrome. This involves moderate fever, nausea, diarrhoea and variable abdominal 
discomfort (Mangni and Arvntikis, 2010). Symptoms occur within 6-48 hours after 
ingestion of the contaminated food or water.  The extent of the diarrhoea is variable, 
from a few loose stools to cholerae–like water diarrhoea, to the less common bloody 
diarrhoea (Gorbach et al., 2004). These symptoms usually resolve within in 3-7 days; 
however severe illness tends to occur in neonates, the elderly and immune 
compromised individuals, and chronic carriers are rare (occurring in less than 1% of 
the infected) (Dutta et al., 2012). 
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Most Salmonella infections result in mild-to-moderate gastroenteritis that usually 
resolves without treatment. However, some lead to severe invasive infections such 
as bacteraemia and meningitis. Invasive Salmonella may invade the body causing 
infections in the bloodstream, tissues such as muscle, fat and those that surround the 
brain and spinal cord. Clinical presentation of iNTS infection typically includes febrile 
systemic illness which resembles enteric fever. Diarrhoea is often absent in iNTS 
cases and the other clinical features observed are often diverse and non-specific 
(Feasey et al., 2012). 
 
Invasive Salmonella infections can be life threatening and therefore hospitalization 
and proper treatment is required. iNTS is commonly known to occur in infants (<1 
year of age), the elderly and those immune-compromised (e.g. HIV infected persons 
and cancer patients). In African countries with a high HIV prevalence, NTS is the 
most common bacteria isolated from blood cultures of hospital admitted febrile adults 
(Vugia et al., 2004; Gordon et al., 2008). iNTS bacteraemia in Africa is reported to 
have a fatality rate between 38%-47% and a recurrence rate of 43% amongst HIV 
infected individuals (Graham et al., 2000b; Galanakis et al., 2007).  
 
In developed countries, invasive Salmonella Enteritidis is less common; however in 
Africa, Salmonella Enteritidis is one of the most commonly iNTS serotypes 
(Galanakis et al., 2007; Gordon et al., 2008). This may be attributed to certain 
virulence strains found in this serotype and its commonality within most African 
countries, thus making infection by this serotype a serious concern to public health 
(Vugia et al., 2004; Galanakis et al., 2007; Gordon et al., 2008).  
 
 
1.7 Pathogenesis  
 
In order for Salmonella to be pathogenic, it needs to possess a variety of virulence 
factors. These include (1) the ability to invade the host cells, (2) a fully equipped 
lipopolysaccharide (LPS) coat, (3) it must be able to replicate intracellularly and (4) it 
must contain a toxin or toxins (Gianella, 1996).  
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Salmonella enters the human digestive system through the consumption of 
Salmonella-contaminated food, water or environmental sources (such as person-
person transmission). In the stomach, the bacterium survives the low acidic 
environment through the use of an adaptive acid tolerance response. The Salmonella 
bacterium then passes onto the small intestine using its peritrichous flagella to move 
and swim chemotactically towards the mucosal surface.  The Salmonella fimbriae 
then adhere to the intestinal epithelium using receptors present on the epithelium. 
After epithelial entry, Salmonella multiplies intracellularly and spreads to the 
mesenteric lymph nodes and to the rest of the body via the systemic circulation. The 
bacterial cells are then taken up by the reticuloendothelial cells, which limit and 
control the bacterial spread. However, depending on the Salmonella serotype and 
the ability of the host immune defense system to fight off the infection, some 
organisms may infect the spleen, gallbladder, liver, bones, meninges, and other 
organs. Fortunately, most Salmonella serotypes are quickly destroyed in the extra-
intestinal sites and most common human Salmonella infections remain confined to 
the intestine (Giannella, 1996; Younus, 2008; Elzouki et al., 2012). 
 
In the case of gastroenteritis, after colonizing the lower intestine (ileum and cecum), 
Salmonella then invades the mucosal cell thus leading to acute inflammation (caused 
by release of cytokines by the epithelial cells) (Giannella, 1996). This inflammation 
leads to activation of the adenylate cyclase, increased production of fluids and the 
release of fluids to the intestinal lumen thus resulting in diarrhoea (Younus, 2008). 
 
 
1.8 Diagnosis and laboratory identification 
 
Salmonella is mainly isolated from a diarrhoeal stool. However, it can be isolated 
from blood culture and cerebral spinal fluid in cases of invasive Salmonella infection 
(Gillespie et al., 2006).  
 
Culture is still the gold standard in the identification and diagnosis of Salmonella. 
These conventional microbiological methods take up to five days, from isolation to 
confirmation. Newer and more rapid methods have been have been developed to 
produce results more quickly, particularly for food and environmental samples. These 
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include immunology based assays such as, enzyme-linked immunosorbent assay 
(ELISA), latex agglutination assay, immunoffusion assay and 
immunochromatography (dipstick) assays. However, there is limited reporting of their 
use on human samples (Lee et al., 2015). 
 
Molecular-based characterization methods used for identification of Salmonella 
include polymerase chain reaction (PCR) and deoxyribonucleic acid (DNA) probe 
hybridization assay. However, the DNA probe hybridization assay positive result still 
requires confirmation using culture based methods (Lee et al., 2015). 
 
1.8.1 Culture methods 
 
Laboratory diagnosis of Salmonella mainly relies on culture. The tests and media 
used to identify Salmonella take advantage of the unique aspects in salmonella’s 
physiology or biochemistry, in order to differentiate it from the other genera within the 
Enterobacteriaceae family. Salmonella is a facultative anaerobe, oxidase-negative, 
catalase-positive and Gram-negative rod. Most Salmonella strains are motile and 
they ferment glucose thus producing acid and gas (Siegrist, 2009).  
 
Many plating media are available for the differentiation and identification of 
Salmonella. They provide varying levels of selectivity; low selectivity media include 
MacConkey agar (MAC) and eosin methylene blue agar. Moderate selective media 
include Xylose-Lysine-Desoxycholate (XLD) agar, desoxycholate citrate agar, 
Salmonella-Shigella agar and Hektoen enteric (HE) agar. Highly selective media 
such as bismuth sulphite agar, XLD and HE have H2S (hydrogen sulphide) indicator 
systems, which helps in the identification of lactose fermenting Salmonella (Murray et 
al., 2007; Siegrist, 2009). Selective plating media are used alongside screening 
media such as the Kliger iron media (KIA) or Triple sugar iron agar. The KIA media 
contains sucrose, ferric ammonium citrate and an indicator. It takes advantage of 
salmonella’s ability to ferment glucose and not sucrose or lactose. In KIA media, 
Salmonella produces colonies with a black centre due to its ability to produce H2S. 
However KIA media test must be used alongside indole and urease tests (Salmonella 
species do not produce indole or hydrolyse urease) and together these results can 
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be used to identify Salmonella as the causative agent of disease (Gillespie et al., 
2006; Murray et al., 2007).  
 
1.8.2 Molecular characterization 
 
1.8.2.1 PCR 
 
PCR is a commonly used molecular diagnostic technique. This technique involves 
the amplification of a single copy or a few copies of a segment of DNA, thereby 
producing thousands to millions of copies of a particular DNA sequence within two to 
three hours.  PCR relies on thermal cycling conditions, which consist of cycles of 
repeated heating and cooling of the reaction, which enables the DNA to melt and 
allow enzymatic replication of the DNA (Chamberlain et al., 1988).  The amplified 
DNA can then be analysed using gel-based systems (the traditional method of 
analysis).  
 
PCR can amplify two or more genes simultaneously in the same reaction (multiplex 
PCR). This reduces cost (reduces the number of PCR reaction runs, thus fewer 
reagents used), and preparation time, and it uses less template DNA (Imen et al., 
2012). Multiplex PCR is therefore being used to identify the Salmonella genus and 
the most common serovars (Porwollik et al., 2004; Porwollik et al., 2005). With the 
introduction of real-time PCR, identification of pathogens has become even quicker 
and less laborious. Several studies have been published on the use of multiplex real-
time PCR for detection of Salmonella species and Salmonella Enteritidis (Malorny et 
al., 2007; Lee et al., 2009). One such published study, done by O’Regan et al., 
(2008) targeted the ttRSBCA gene for detection of Salmonella species and the sdf 
gene for the detection of Salmonella Enteritidis.  
 
 
1.9 Salmonella subtyping 
 
Subtyping methods (phenotypic and genotypic) enable differentiation of bacterial 
isolates beyond the genus level (i.e. species and subspecies level). Bacterial 
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subtyping methods enable us to detect and track foodborne outbreaks. Furthermore, 
they allow us to better understand the population genetics, epidemiology, and 
ecology of different foodborne pathogens (Wiedmann, 2002). 
 
1.9.1 Phenotypic subtyping 
 
Although culturing is used to identify Salmonella, identification to Salmonella species 
level is required. Phenotypic subtyping methods such as serotyping and phage typing 
have been used for many years. However, these methods are time and labour 
intensive and may have variable discrimination (Wiedmann, 2002). 
 
1.9.1.1 Serotyping 
 
Serotyping is considered the gold standard for phenotypic subtyping of Salmonella. 
Salmonella serotyping involves specific agglutination reactions between absorbed 
antisera and specific epitopes present on the lipopolysaccharide (LPS) (O antigen, 
encoded by the rfb genes) or flagella (H phase 1 and 2 antigens, encoded by the fliB 
and fliC genes) of the Salmonella bacteria. These antigens (46 O and 85 H antigens) 
are used in the differentiation of over 2500 Salmonella serotypes (Dwarkin and 
Alkow, 2006). Salmonella Enteritidis falls under the O:9 (D1) serogroup, with the  
antigenic formula 1,9,12:g,m:-. Furthermore, Salmonella Enteritidis lacks a phase 2 H 
antigen. 
 
The O antigen is situated on the outer membrane of the bacterial cell known as the 
LPS. The LPS is an essential element responsible for maintaining the integrity of 
Gram-negative bacteria. The LPS also plays a major role in the interaction of the 
bacterium with the host and thus resulting in dramatic pathophysiological effect on 
the host’s immune system.  The LPS is one of the elements that gave rise to 
serotyping due to its high immunogenicity with the antibodies that are produced with 
specificity to the LPS polysaccharide glycosyl epitopes (O antigen). The O antigen is 
the most immunodominant region of the LPS; its structure is very variable amongst 
Salmonella strains (Cabello et al., 1993; Dwarkin and Alkow, 2006). 
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Salmonella H antigens are encoded by one of two genes, namely the FliC and FliB. 
The FliC gene is responsible for the expression of the phase 1 H antigens, whilst the 
FliB gene expresses the phase 2 H antigens. The FliC gene is situated in one of the 
operons responsible for flagella biosynthesis and it is present in all Salmonella. The 
FliB gene is situated in the part of the genome that is unique to Salmonella enterica 
and it is present in 4 of the 6 Salmonella enterica subspecies (enterica, salamae, 
diarizonae and indica). These two genes are coordinately regulated through a phase 
variation mechanism, so that only one flagella antigen type can be expressed at a 
time in a single bacterium. However, in other instances, certain serotypes can 
express both flagellin types simultaneously (diphasic), whilst other serotypes contain 
only one flagellar antigen type (monophasic). Sequence alignment has shown that 
the 5’ and 3’ ends of both the FliC and FliB genes are highly conserved, with the 
central regions of the sequences showing high variability between immunologically 
distinct antigen types and this is presumed to be the basis of antigenic differences of 
flagellar antigens (McQuiston et al., 2010). 
 
However, negative agglutination can also occur due to the presence of a new 
serotype or/an unusual serotype and sometimes due to the presence of a capsular 
antigen (Vi antigen), which is present in only 3 Salmonella serovars: Salmonella 
Typhi, Salmonella Paratyphi C and Salmonella Dublin (Chart et al., 2000). In other 
instances, Salmonella organisms can be found in the non-specific phase and 
therefore variation can be induced by cultivating the isolate in semi-solid agar 
containing antisera against phase H 2, which will then select for phase H 1 (Gianella, 
1996; Gillespie et al., 2006).   
 
It is these unique Salmonella characteristic traits that lead to the development of the 
Kauffman-White-Le Minor scheme (Grimont and Weill, 2007), for serotyping of 
Salmonella. This scheme is currently used worldwide to ensure uniformity within the 
Salmonella nomenclature, which is essential for appropriate communication amongst 
scientists and health officials around the world (Gianella, 1996; Murray et al., 2007). 
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1.9.1.2 Phage typing 
 
Phage typing is a non-molecular technique used to categorise certain Salmonella 
serotypes to a particular group based on their susceptibility to lysis by certain types 
of bacteriophage (virus that infects bacteria and replicates within it). Many 
Salmonella serotype strains differ in their susceptibility to lysis by different 
bacteriophages; this led to the development of a typing scheme based on reactivity to 
a panel of bacteriophage. In phage typing, Salmonella strains are exposed to a 
specific set of typing phages and the lytic pattern produced allows the assignment of 
the strain to a particular phage type.  
 
Phage typing has been used in the typing of a number of serotypes including 
Salmonella Typhimurium, Salmonella Enteritidis and Salmonella Typhi (Threlfall and 
Frost, 1990; Threlfall, 2000). The technique is commonly used for surveillance and 
subtyping of Salmonella, and provides results easily and rapidly (within 24 hours).  
However, it is performed in few laboratories due to its requirement for standardized 
phage panels. Furthermore, phage typing could have less discrimination capacity for 
serotypes such as Salmonella Enteritidis, which has phage type 4 (PT4) as the most 
common infectious strain. This phage type is said to account for 75% of all 
Salmonella Enteritidis isolated during outbreaks (Hickman-Brenner et al., 1991; 
European Food Safety Authority, 2007).  Despite its potential drawbacks, phage 
typing is one of the most commonly used techniques to subtype Salmonella 
Enteritidis (Cho et al., 2007). 
 
1.9.2 Molecular subtyping 
 
Molecular subtyping techniques address epidemiologic problems that cannot be 
approached or that would be more labour intensive, expensive, and time consuming 
to address by conventional non-molecular techniques (Foxman and Riley, 2001). 
Currently molecular subtyping techniques are based on restriction enzyme digestion, 
nucleic acid amplification or nucleotide sequencing techniques (Imen et al., 2012). 
Some of the most commonly used molecular techniques for subtyping of Salmonella 
include plasmid profiling, pulsed-field gel electrophoresis (PFGE), ribotyping, PCR, 
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multi-locus sequence typing (MLST), multi-locus variable-number tandem-repeats 
analysis (MLVA), and whole-genome sequencing (WGS) analysis.  
 
1.9.2.1 Plasmid profiling 
 
Plasmid profile analysis is one of the original DNA-based subtyping schemes. 
Plasmids are important because, most of them contain genes that encode for 
virulence and antimicrobial resistance. Plasmid profiling has proven to be useful 
because it has been shown that regardless of same serotype association, the 
plasmid content can differ based on the profile (the number and molecular size of the 
plasmid) obtained. The presence of different plasmid profiles in the same serotype 
indicates that lateral transfer through the gaining or loosing of plasmids occurs. 
Plasmid profiling is used for Salmonella because the plasmids found in this 
microorganism have been shown to differ in size 2-200 kilobases (kb) and have 
different functions (Rychlik et al., 2006). The method is based on isolation of the 
plasmids from the bacterial cell. The plasmids are then run on an agarose gel, which 
is then stained with ethidium bromide solution and viewed under ultraviolet (UV)-light 
(Helmuth et al., 1985). 
 
Like many other techniques, plasmid profiling has limitations; plasmids can be rapidly 
acquired or lost. Furthermore, single major plasmids are now endemic within many 
Salmonella serotypes, and such was seen with Salmonella Enteritidis were 88% of 
the isolates in a particular outbreak in Maryland USA were found to all contain one 
main 36-Mda plasmid (Morris et al., 1992). Thus, the technique is most effective if the 
serotype of interest carries multiple plasmids with different sizes (Mendoza et al., 
1999). 
 
1.9.2.2 Pulsed-field gel electrophoresis (PFGE) 
 
PFGE is currently the primary technique for subtyping of Salmonella. PulseNet 
International (an international molecular subtyping network) uses standardized PFGE 
protocols for various bacterial pathogens, and this allows for effective inter-laboratory 
comparison and sharing of PFGE data amongst the PulseNet network (Swaminathan 
et al., 2001; Ribot et al., 2006). Through its use on the PulseNet network, PFGE has 
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had a major impact on pathogen subtyping, surveillance and outbreak investigation 
(Ribot et al., 2006).  
 
PFGE involves the cutting of bacterial DNA with rare-cutting restriction 
endonucleases and running the DNA on a special electrophoresis unit, which uses 
pulsed currents that change polarity at certain intervals. These pulsed currents 
enable separation of large fragments of DNA (up to 12 000 kb), therefore producing 
strain specific patterns (Peters et al., 2007).  
 
A number of restriction endonucleases are specified for PFGE use. However XbaI, 
SpeI and NotI are the most commonly used restriction endonucleases for Salmonella 
subtyping. The discriminatory power of this technique can further be enhanced by the 
comparison of strain patterns produced from multiple enzymes, since it can reveal 
new subtypes (Liebisch & Schwarz, 1996). The success of such an approach was 
illustrated when 60 Salmonella Enteritidis isolates were cut by Xbal and they 
produced 28 different patterns and the same isolates produced 26 different patterns 
when cut with SpeI. Furthermore, when the patterns generated by the two restriction 
enzymes were combined, 32 different PFGE types were identified (Ridley et al., 
1998). 
 
PFGE is a highly reproducible technique and the introduction of computerized gel-
based data collection and analysis has allowed for better standardization and 
comparison of patterns between laboratories (Swaminathan et al., 2001).  
 
Despite the fact that PFGE is the primary technique for molecular subtyping of 
Salmonella, it is however not always successful.  Other serotypes (mainly those with 
certain distinct phage types) are genetically homogeneous and therefore molecular 
subtyping techniques such as PFGE are unable to discriminate outbreak from non-
outbreak strains, as seen with strains of Salmonella Enteritidis (Hopkins et al., 2011). 
This was observed during a Canadian-wide outbreak of gastroenteritis, wherein 
Salmonella Enteritidis strain DT8 was isolated.  The Salmonella Enteritidis DT8 strain 
was evaluated using PFGE; nonetheless successful discrimination was only attained 
through the combination of intensive epidemiological, phenotypic and genotypic 
methods (Ahmed et al., 2000).  
19 
  
Additionally, PFGE is laborious and time consuming (takes minimum 3 days to 
complete), it requires expensive specialised equipment (which may not be affordable 
for developing countries) and it also requires experienced personnel (experienced 
staff may be scarce in developing countries and budget for training may be limited) 
(Herschleb et al., 2007). 
 
1.9.2.3 Ribotyping 
 
 
Ribotyping is a technique used to fingerprint ribosomal ribonucleic acid (rRNA) 
coding sequences. The technique involves the running of endonuclease-digested 
DNA through an agarose gel and then transferring the DNA fragments onto a 
membrane, which enables the DNA fragments to be hybridized to a probe that 
recognizes the 16SrRNA and 23SrRNA (Millemann et al., 1995). 
 
Several copies of the rRNA operon exist in the Salmonella chromosome. The rRNA 
genes in this operon are very homologous. However, the interfering sequences tend 
to differ in their length and nucleotide composition (Mendoza et al., 1999; Imen et al., 
2012). Ribotyping has been shown to successfully subtype isolates that fall within 
some of the most common serotypes and phage types (Landeras et al., 1996). Lin et 
al., (1996) identified 7 different ribotypes from 17 Salmonella Enteritidis phage type 8 
(PT8) isolates whose chromosomal DNA was digested with SphI.  
 
1.9.2.4 PCR-based methodologies 
 
 
A number of PCR-based subtyping methodologies have been described and these 
include random amplified polymorphic DNA (RAPD) assay and repetitive extragenic 
palindromic (REP)-PCR (Olive and Bean, 1999). 
 
The RAPD assay, also referred to as arbitrary primed PCR, is based on the use of 
short random sequence primers (~9-10 bases long) that hybridize to chromosomal 
DNA sequences at low annealing temperature, in order to be used to initiate 
amplification  of regions of the bacterial genome. If two RAPD primers anneal within 
few kb of one another, a PCR product with a molecular length corresponding to the 
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distance between the two primers is produced. The number and location of these 
random primers tend to vary for different bacterial strains. Thus following separation 
of the PCR products by agarose gel electrophoresis, a pattern of bands which are 
characteristic (theoretically characteristic) to the particular bacterial strain are 
produced (Olive and Bean, 1999). 
 
REP-PCR involves the fingerprinting of a bacterial genome by examining strain-
specific patterns obtained from PCR amplification of repetitive DNA elements present 
within the bacterial genome. This assay consists of two main sets of repetitive 
elements (repetitive extragenic palindromic elements and enterobacterial repetitive 
intergenic consensus sequences), used for the typing process. The enterobacterial 
repetitive intergenic consensus sequences were primarily defined based on 
sequence data obtained from Salmonella Typhimurium and E. coli. This has enabled 
REP-PCR to generate unambiguous DNA fingerprints for differentiation of eubacterial 
species and strains (Olive and Bean, 1999). 
 
Both assays have been successfully applied in the subtyping of Salmonella 
Enteritidis. Furthermore, advancement in their technologies have allowed for reduced 
preparation times and quicker results (Olive and Bean, 1999). 
 
1.9.2.5 Multi-locus sequence typing (MLST) 
 
MLST is a molecular typing technique that compares DNA sequences from internal 
regions of housekeeping or virulence genes and/or rRNA sequences, which tend to 
differ due to mutations or recombination events (Maiden et al., 1998). 
 
The nucleotide differences found in each of the genes are combined and used to 
determine the type of strain (Yan et al., 2003). MLST produces data that is similar to 
that obtained by multi-locus enzyme electrophoresis, but in greater detail.  This is 
because MLST has the ability to analyse individual nucleotide changes, rather than 
assessing the overall change in charge and expression of the enzyme in question 
(Maiden et al., 1998). 
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MLST is a useful technique for long-term epidemiological studies or phylogenetic 
analysis. Its potential use in Salmonella subtyping was observed from its ability to 
characterize over 200 salmonella’s using sequences from the different housekeeping 
genes (Kotetishvili et al., 2002). These results were compared to those of PFGE and 
serotype analysis. It was shown that MLST was able to differentiate the strains 
better. This technique shows great potential in the accurate sharing of information 
between laboratories. Nonetheless MLST is still expensive and may be unaffordable 
in developing countries (Imen et al., 2012). 
 
1.9.2.6 Multi-locus variable-number tandem-repeats analysis 
(MLVA) 
 
MLVA is a subtyping method that uses naturally occurring variation in the number of 
tandem repeated DNA sequences found in the genome of most bacterial species. It 
is this polymorphism that occurs in repeat loci regions that makes MLVA a well 
discriminative (good typing) method (Kramer et al., 2010; Koninklijke Nederlandse 
Vereniging voor Microbiologie, 2014).  
 
Tandem repeats are made up of two or more identical or nearly identical short DNA 
sequences that are not combined with any intervening DNA sequence. These 
tandem repeats are the result of errors made by the DNA polymerase, which 
incorrectly copies these segments by a mechanism called slipped strand mispairing. 
During replication, DNA polymerase stumbles in certain regions of the genome, 
therefore resulting in some DNA regions being duplicated or deleted. This DNA 
polymerase error can occur numerous times and may cause some regions to be 
multiplied several times and the size of these tandem repeat units can range from 3 
to 100 base pair. The stuttering results in variation in the number of repeats, hence 
the name “variable number tandem repeat” (VNTR) (Kramer et al., 2010). 
 
There are two different types of mechanisms by which variation in the number of 
tandem repeats can be generated. The first mechanism is replication slippage (also 
known as backward replication slippage), which occurs when the DNA polymerase 
copies the template DNA and then stutters in areas where tandem repeats are 
located, resulting in increased numbers of repeats (Figure 1.2). The second 
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mechanism is the forward slippage, which occurs if a tandem repeat region contains 
a large repeat sequence and during replication the single stranded genomic DNA 
forms a loop in the repeat region. The DNA polymerase then mistakenly skips this 
looped region and thus producing a replicated strand that has a smaller tandem 
repeat sequence (Figure 1.3) (Koninklijke Nederlandse Vereniging voor 
Microbiologie, 2014).  
 
 
Figure 1.2. Mechanism of replication slippage (Koninklijke Nederlandse Vereniging 
voor Microbiologie, 2014).  
 
 
Figure 1.3. Mechanism of forward slippage (Koninklijke Nederlandse Vereniging voor 
Microbiologie, 2014). 
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The MLVA method involves performing a PCR to amplify the repeat regions in the 
bacterial genome. The size of the PCR product is then analysed using a multicolour 
capillary gel electrophoresis or by sequence analysis. The PCR product sizes are 
then used to determine the number of repeats in each region. Therefore, by 
combining the size differences from several repeat loci regions, a multi-digit, strain 
specific code (profile) can be acquired and these profiles can therefore be used for 
cluster analysis. The introduction of DNA sequencers in product sizing has made 
MLVA a much reliable method and the numerical aspect of the data makes it suitable 
for inter-laboratory exchange (Kramer et al., 2010).  
 
MLVA’s performance (reproducibility and epidemiological relevance) is highly 
dependent on the stability of its target sequence. Some VNTR’s however are 
unstable and can therefore lead to strain separation during an outbreak, thus 
confounding the actual epidemiology. In other occasions extremely unstable VNTR’s 
can even undergo change during routine laboratory sub-culturing and therefore affect 
the reproducibility of the MLVA method. Another possible MLVA drawback is that, 
since the primers used to amplify the VNTR’s are designed based on currently known 
whole genome sequences, it cannot be possible to successfully amplify all VNTR’s 
from all strains in the same species, therefore making typeability a challenge. For 
example an insertion within a VNTR region would change the VNTR size, thus 
confounding the VNTR size analysis. This signifies the importance of VNTR selection 
and primer design in developing an epidemiologically relevant MLVA scheme 
(Wiedmann and Zhang, 2011). 
 
Although MLVA is a fragment-based method, its use of consistent molecular 
markers, PCR and capillary electrophoresis produces a more phylogenetically 
significant and less-ambiguous product, thus making it more advantageous in 
comparison to other fragment-based subtyping methods. MLVA’s discriminative 
properties were observed by Boxrud et al., (2007), where they evaluated MLVA, 
phage typing and PFGE for the subtyping of Salmonella Enteritidis. Their 
discriminatory indexes were 0.965, 0.850 and 0.839 respectively, thus demonstrating 
MLVA’s potential as a reliable and fast subtyping method for Salmonella Enteritidis. 
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To date, a number of MLVA schemes for Salmonella Enteritidis have been published 
(Boxrud et al., 2007; Cho et al., 2007; Cho et al., 2008; Malorny et al., 2008; Ross 
and Heuzenroeder, 2009). However, a difference in the MLVA setups and data 
interpretation makes comparison of data between laboratories a challenge. Another 
challenge with MLVA is that there are limited published data available describing the 
stability of loci regions and the speed at which tandem repeats evolve, and if such 
evolution can occur during an outbreak caused by a single ancestral isolate. Such 
concerns may threaten the use of MLVA for Salmonella Enteritidis outbreak detection 
unless specific guidelines are developed for performing MLVA and a common 
procedure is reached on how to interpret the MLVA data, as seen in MLVA for 
Salmonella Typhimurium (Larsson et al., 2009; Hopkins et al., 2011). 
 
Hopkins et al., (2011) emphasized the standardization of MLVA for Salmonella 
Enteritidis by implementing guidelines for the MLVA protocol, result analysis and 
interpretation. The use of this protocol in laboratories around the world will ensure 
preservation of this technique for Salmonella Enteritidis subtyping.  
 
In their study, Hopkins et al., (2011) identified 71 different MLVA profiles from 298 
Salmonella Enteritidis isolates, thereby showing MLVA to be a promising subtyping 
method for this Salmonella serotype. Furthermore, MLVA was able to subtype 
isolates that belonged to the same phage type and in most cases isolates from 
different phage types clustered together. A similar finding was previously observed 
by Malorny et al., (2008) and Cho et al., (2010). 
 
1.9.2.7 Whole-genome sequencing (WGS) analysis 
 
Despite the fact that good clinical results are obtained from the serological and 
molecular methodologies mentioned above, the techniques however give limited 
information about the pathogenic organism. WGS analysis is changing this. The 
technique has greatly improved since its inception, with the reduction in process time 
as well as the move of WGS into high-throughput next generation sequencing 
technology, with comparatively simple benchtop technology and efficient library 
preparation. Furthermore, the technology is becoming cheaper and more user- 
friendly. 
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WGS involves the determination of the complete DNA sequence of an organism’s 
genome at a single time, thus attaining all information regarding its genetic make-up. 
This gives more information beyond identification level (Hasman et al., 2014).  
 
For genetically monomorphic bacteria such as Salmonella Enteritidis, Salmonella 
Montevideo, Staphylococcus aureus and many others, the current typing methods 
are not adequate for outbreak detection, trace backs, and identification of 
transmission routes. The use of WGS analysis on these organisms has shown better 
discrimination compared to other molecular typing methods (Den Bakker et al., 
2014).  
 
Numerous studies describing WGS analysis for Salmonella Enteritidis have been 
published. A study by Feasey et al. (2016) analysed Salmonella Enteritidis isolates 
from 45 countries (from six continents). They found evidence of three clades 
(grouping of organisms with a common ancestor); the global epidemic clade and two 
African clades (West African clade and Central/Eastern African clade). The study 
was able to link the global epidemic clade with foodborne outbreaks associated with 
chicken eggs in Europe. The West African clade and Central/Eastern African clade 
were shown to be related; however they were phylogenetically and geographically 
distinct from one another. The Salmonella Enteritidis strains in these two clades were 
also different from those in the industrialized world. These strains showed evidence 
of changing host adaptation, different virulence determinates and multidrug 
resistance. Furthermore, these strains had possible links to epidemics of 
bloodstream infection in at least three countries in Sub-Saharan Africa. Interestingly, 
the study also showed that the South African Salmonella Enteritidis strains were 
associated with the global epidemic clade. 
 
Currently PFGE is the primary technique for typing Salmonella species; however 
PFGE has limited discriminatory power for Salmonella Enteritidis strains and clusters, 
and although MLVA improves discrimination of disease clusters, it still assigns 30% 
of isolates to a single MLVA type (Den Bakker et al., 2014). 
 
A study by Den Bakker et al. (2014) comparing WGS to PGFE and MLVA, 
demonstrated that whole-genome cluster analysis of Salmonella Enteritidis showed 
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vast improvement on the detection of clusters of common PFGE types, as well as 
improving outbreak resolution. Furthermore, comparison of WGS analysis to MLVA 
gave corresponding results (multiple types) and PFGE had given a single type, which 
yielded no useful molecular clustering information (Den Bakker et al., 2014). 
 
Despite well-published success on the typing of various bacterial organisms, the full 
potential of WGS has not been fully explored. Currently, majority of the WGS 
analysis is based on single nucleotide variants or single nucleotide polymorphisms 
(SNPs) that have been identified from comparisons to an already present reference 
genome sequence. Consequently, analysis is thus dependent on the quality of 
sequencing, genome assembly, as well as the quality and selection of the reference 
genome. SNPs comparative analysis excludes a significant proportion of 
phylogenetic data and some bioinformaticians have even suggested conducting 
phylogenetic analyses based on all loci in a genome, rather than solely analysing 
SNPs (Bertels et al., 2014). However, such analysis would require large computer 
resources and time (Kwong et al., 2015). Although the cost of WGS has significantly 
decreased, it is still unaffordable for most African countries. However, in South Africa, 
WGS is being explored in research facilities.  
 
 
1.10 Treatment and management  
 
Infection by NTS such as Salmonella Enteritidis tends to be mild and resolve easily 
without any treatment by antimicrobials. Antimicrobial treatment of uncomplicated 
salmonellosis is contra-indicated because it tends to extend the carrier state 
(D'Aoust, 1991; Chiu and Su, 2014). However, in order to prevent dehydration and 
electrolyte imbalances of the uncomplicated cases, replacement fluids and 
electrolytes are administered to the patient (Chiu and Su, 2014).  
 
Antimicrobial treatment is administered in severe and complicated cases such as in 
patients with prolonged fever and those that are immune-compromised (such as 
infants, the elderly, HIV infected, cancer patients etc.). This is to prevent further 
morbidity or mortality amongst these high-risk groups (Alcaine et al., 2007). The first 
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line of treatment often includes fluoroquinolones like ciprofloxacin or a third 
generation cephalosporin β-lactam such as ceftriaxone, penicillins such as ampicillin 
and folic acid pathway inhibitors (sulfonamides). However, children and pregnant 
women are treated with β-lactams, because fluoroquinolones interfere with cartilage 
formation (Barceloux, 2012; Chiu and Su, 2014).  
 
In healthy patients, antimicrobials are often prescribed and administered for 5 days in 
order to limit faecal carriage that may occur with prolonged use of antimicrobials 
(Hohmann, 2001). In patients with systematic disease, antimicrobials are 
administered for a longer period of time (3-4 weeks), to ensure effective drug 
penetration and treatment as well as to prevent recurrence (Mangni and Arvntikis, 
2010). In circumstances where infection is caused by first line drug-resistant 
Salmonella; second line drugs such as aminoglycosides, sulfonamides like 
cotrimoxazole are therefore used (Guerrant et al., 2001; Chiu and Su, 2014). 
Treatment of multidrug-resistant Salmonella infections includes carbapenems such 
as imipenem or meropenem that are administered intravenously (Alanis, 2005; 
Huehn et al., 2010; Chiu and Su, 2014). 
 
 
1.11 Antimicrobial resistance 
 
Antimicrobials play an important role in the controlling of bacterial infections, reducing 
morbidity and in preventing mortality. It is estimated that antimicrobials increase life 
expectancy by 20 years. These compounds have not only saved human life, but have 
also saved life-stock in the agricultural industry (Alanis, 2005; National Department of 
Health, 2015). However the extensive use of these substances has resulted in 
bacterial resistance, thus threatening to reverse the life-saving power of these drugs. 
It is estimated that 25000 patients die in Europe each year from resistant bacterial 
infections and in South-East Asia 1 child dies every five minutes from a resistant 
bacterial infection (National Department of Health, 2015). 
 
Antimicrobial resistance is a serious problem, which requires immediate global 
attention, because certain microorganisms have become extremely resistant to all 
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the existing antimicrobials; such events have been mainly described in Gram-
negative rods such as Escherichia coli (E. coli), Salmonella species, Klebsiella 
species and Acinetobacter species (Hughes, 2011).  
 
On the other hand, the production of new antimicrobials has become slow; few 
antimicrobials have been produced in the past decade (Hughes, 2011). Several 
powerful compounds, which are active against Gram-positive cocci, have been 
produced in the last few years. However, this has not been the case with Gram-
negative bacteria and there is almost no new drugs that can be anticipated to be 
effective against multidrug-resistant Gram-negative rods in the near future (Carlet et 
al., 2012).  
 
1.11.1 Drivers of antimicrobial resistance 
 
The most important drivers of antimicrobial resistance include the amount of 
antimicrobials used, dependence on broad-spectrum antimicrobials and acquisition of 
hospital acquired infections (National Department of Health, 2015). 
 
It is estimated that 50% of all antimicrobials prescribed to humans are unnecessary, 
since in many cases there is no infection or the infection is not caused by a 
bacterium or the antimicrobials are prescribed for an unnecessary expended period 
of time. It is also estimated that 80% of all antimicrobials used globally are used in 
agriculture and animal health for prevention, treatment and growth promotion 
(National Department of Health, 2015). Broad-spectrum antimicrobials have activity 
against a wide range of different bacteria and this may lead to the selection of a 
greater range of resistant populations compared to narrow-spectrum antimicrobials. 
The rising levels of bacterial resistance in hospitals and community settings, 
increases the need for use of empirical antimicrobials with a broader spectrum of 
activity. Therefore, escalating the selection of resistant bacteria within the human 
population (National Department of Health, 2015). Hospitalized patients are at high 
risk of developing multidrug-resistant bacterial infections, because they are often 
immune-compromised and poor hygiene practices by health care professionals may 
leave them vulnerable to such infections, mostly during the performance of invasive 
procedures (National Department of Health, 2015). 
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1.11.2 Mechanisms of antimicrobial resistance 
 
Resistance to antimicrobials was detected in the target pathogens, a few years into 
their use as therapeutic agents in humans. Selective pressure created by their 
extensive use was the driving force in the emergence of genetically encoded 
resistance, which could be transferred to the offspring bacterium and in other events 
resistance, could be caused by horizontal gene transfer to even distant bacterial 
species (Linton, 1977; National Department of Health, 2015). 
 
Mechanisms of antimicrobial resistance mainly fall into three categories: (1) 
inactivation of the antimicrobial agent, (2) efflux or alterations in permeability or 
transport of the antimicrobial agent, and (3) modification or replacement of the 
antimicrobial target site (McDermott et al., 2003; Walsh, 2003; Boerlin and Reid-
Smith, 2008; Foley and Lynne, 2008).  
 
Antimicrobial resistance is encoded genetically and can vary from mutations that are 
found in the chromosomal DNA, to horizontally acquired resistance genes that are 
carried by mobile genetic elements such as plasmids. Both point mutations and 
horizontally acquired genes can encode for all the three mechanisms of resistance.  
 
Point mutations that occur in the promoter or operator coding regions can lead to 
overexpression of the endogenous genes such as those that encode for antimicrobial 
inactivating enzymes like the β-lactamase AmpC gene (Siu et al., 2003). Point 
mutations that occur in genes encoding for antimicrobial target regions can result in a 
target site that is resistant to the antimicrobial activity. Such a mutation was seen in 
the gyrase gene, whose mutation led to the expression of a fluoroquinolone-resistant 
gyrase enzyme (Eaves et al., 2004; Hopkins et al., 2005).  
 
Non-chromosomal resistance genes encoded on plasmids, integrons, phages and 
transposons can be transferred horizontally through transformation, transduction or 
conjugation. These exogenous DNA’s include genes which encode for enzymes that 
inactivate antimicrobials (e.g. β-lactamases that cleave the four membered ring in β-
lactams), genes which encode for efflux systems (which expels the drug out of the 
bacterial cell) and genes that encode for an altered form of the enzyme that is 
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targeted for by the antimicrobial agent (Boerlin and Reid-Smith, 2008; Ajiboye et al., 
2009; Carattoli, 2009). 
 
1.11.3 Resistance to antimicrobials used for Salmonella treatment 
 
Although most Salmonella cases are mild and require no treatment, complicated 
cases require antimicrobials and antimicrobial resistance often leads to treatment 
failures and potential death of patients by pathogens that were once treatable. 
Salmonella is already a huge burden globally and resistant Salmonella strains 
threaten to cause a global pandemic, leading to the loss of millions of lives (D'Aoust, 
1991). Antimicrobials used for the treatment of complicated Salmonella infections 
include penicillins, fluoroquinolones, cephalosporins, tetracyclines, sulfonamides and 
macrolides to name a few (Parry and Threlfall, 2008; Barceloux, 2012).  
 
Ampicillin is one of the most commonly used extended-spectrum penicillin 
antimicrobial worldwide (Root et al., 1999). Ampicillin is used in the treatment of 
complicated Salmonella Enteritidis cases. However, due to changes in susceptibility, 
it is no longer the drug of choice unless culture and sensitivity results indicate 
susceptibility (Barceloux, 2012). Although human ampicillin-resistant Salmonella 
Enteritidis isolate cases exist, there have been limited reports in literature. However, 
ampicillin resistance has been widely reported in other NTS serovars such as 
Salmonella Typhimurium (Mølbak et al., 1999; Pignato et al., 2010).  
 
Fluoroquinolones are a family of synthetic antimicrobial agents, whose mode of 
activity involves the inhibition of topoisomerases (Hooper, 2001; Lorian, 2005). 
Fluoroquinolones such as ciprofloxacin are used in treatment of Salmonella 
infections. There is limited data on ciprofloxacin resistance by Salmonella Enteritidis; 
however Cheung et al. (2005) reported on plasmid mediated ciprofloxacin resistance 
of Salmonella Enteritidis in Hong Kong. Several studies have also described reduced 
susceptibility and intermediate resistance of Salmonella Enteritidis to ciprofloxacin 
(Threlfall, 2002; Eibach et al., 2016). 
 
Ceftriaxone is an extended-spectrum cephalosporin, generally used to treat severe 
Salmonella infections and are the main drug of choice when treating patients for 
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whom fluoroquinolones are contra-indicated. Cephalosporin resistance amongst 
human Salmonella isolates is still low. Nonetheless, there is a continual increase of 
cephalosporin resistance in Salmonella isolates from animals, thus threatening food 
safety and human health (Goetez, 2012). Bacterial pathogens resistant to extended-
spectrum cephalosporins such as ceftriaxone carry a plasmid-mediated AmpC-like 
beta-lactamase enzyme (encoded by the blaCMY gene), which hydrolyses 
cephalosporins. Salmonella isolates carrying the blaCMY gene have been isolated 
from bovine, porcine, human, and foods sources (Gray et al., 2004).  
 
Tetracyclines are broad-spectrum antimicrobials, which are also used in the 
treatment of Salmonella infections. Tetracyclines mode of action is the inhibition of 
protein synthesis at the ribosome.  Several different tet genes have been described 
to confer resistance to tetracyclines in Salmonella species. These genes have been 
detected on chromosomes of different Salmonella enterica serotypes including 
Salmonella Enteritidis, Salmonella Typhimurium, Salmonella Hadar, Salmonella 
Saintpaul, and Salmonella Choleraesuis (Pezzella et al., 2004). 
 
Sulfamethoxazole and trimethoprim are one of the most common sulfonamides used 
in the treatment of infections caused by enteric pathogens such are E. coli, Shigella 
and Salmonella. Sulfamethoxazole is often used in combination with trimethoprim in 
a 5:1 ratio, with the trade name cotrimoxazole (Hamer and Gill, 2008; Sibanda et al., 
2011). Sulfamethoxazole and trimethoprim (cotrimoxazole) are used as prophylactic 
drugs in HIV/Aids infected patients, as a means to prevent life threatening 
opportunistic infections in this risk group. This extensive use of cotrimoxazole within 
the HIV/Aids infected population is based on studies that were conducted in Africa 
showing reduced HIV-associated mortality and morbidity in sulfamethoxazole and 
cotrimoxazole users (Sibanda et al., 2011). Since the introduction of antiretroviral 
drugs, the prophylactic use of cotrimoxazole in developed countries has been greatly 
reduced. However, most African countries continue with this use of cotrimoxazole. 
Therefore, it is highly plausible that sulfonamide resistance may be attributed to the 
extensive use of these drugs in most African settings. Furthermore, the use of 
sulfonamides in the agricultural industry for animal prophylaxis might be playing a 
major role in their resistance (McEwen and Fedorka-Cray, 2002; Swartz, 2002; 
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Hamer and Gill, 2008; Morpeth et al., 2009). Resistance genes are often located on 
plasmids (Chiu and Su, 2014). 
 
Macrolides are one of the most well established classes of antimicrobials used today. 
One of the most commonly used macrolides is azithromycin; this antimicrobial has 
been shown to have varying levels of activity against the family Enterobacteriaceae. 
However, it is effective against Salmonella and Shigella species (Parnham et al., 
2002; Gaynor and Mankin, 2003). The high level of activity, safety, as well as their 
use as a penicillin alternative for allergic patients, has made macrolides a popular 
drug of choice. Such has led to the extensive use of these drugs and therefore aiding 
to the emergence and spread of resistant bacterial strains (Weisblum, 1995). 
Azithromycin resistance has not been reported in Salmonella Enteritidis.  
 
 
1.12 Prevention 
 
Prevention of salmonellosis is closely linked with food safety and therefore stringent 
regulations have to be emphasized in the food industry by government departments 
such as health and agriculture (FAO and WHO, 2002). The issue of foodborne 
disease prevention is very complex and complicated, because it involves several 
stages in food production such as processing, storage and transportation. Poultry, 
poultry products and meat products are the most commonly reported sources of 
Salmonella infection, therefore emphasis is required to ensure correct food safety 
and appropriate hygienic precautions are carried out (Mangni and Arvntikis, 2010).   
 
Government departments cannot prevent foodborne diseases alone. The public has 
to be well informed about the risks involved in consumption of certain food products 
and also measures they can take to prevent infection. Another important aspect in 
the prevention of foodborne enteric infections relates to measures that have to be 
taken to ensure that restaurants conform to safety regulations when storing and 
preparing food. Regular monitoring (questionnaire based) of personnel who might be 
harbouring an enteric infection or not following proper hygienic procedures should be 
emphasized. Furthermore, hygienic practices should also be emphasized in 
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hospitals, children’s day cares and in private homes. This is because food might 
have been safe during selection in supermarkets, but may become unsafe by the 
time it’s consumed (Mangni and Arvntikis, 2010).   
 
 
1.13 Vaccines 
 
With food as the major route of transmission, reduction of Salmonella Enteritidis 
infections is a major global challenge and vaccination of food animals and/or humans 
may play a role in the fight against this pathogen. Animal vaccination would reduce 
the number of contaminated food animals and therefore reduce human infections 
caused by consumption of contaminated food. However, the theoretical efficacy of 
vaccines that prevent animal infection by Salmonella is uncertain. The main 
challenge is that most Salmonella serotypes, which colonise the animal species and 
are then passed on to humans, are actually part of the normal flora of these animals. 
Therefore the design of any vaccine to inhibit infection by “normal flora” is a 
challenging task (Chiu and Su, 2014). However, there are a number of live 
attenuated Salmonella vaccines licensed for use in poultry, swine and cattle industry 
(Chiu and Su, 2014).  
 
 
1.14 Salmonella Enteritidis in food animals 
 
Salmonella Enteritidis zoonotic capabilities enable it to infect both humans and 
animals successfully. Food animals have become a pathway for human infection by 
Salmonella Enteritidis, making this Salmonella serovar a pathogen of global concern 
(Mangni and Arvntikis, 2010; Gal-Mor et al., 2014).   
 
Salmonella Enteritidis is one of the most common Salmonella serovars isolated from 
food animals and food products. In farm animals, this pathogen is commonly isolated 
from poultry and chicken eggs. Although it can also be isolated from other farm 
animals such as swine, cattle and sheep; Salmonella Enteritidis infections in these 
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animals are considered less important compared to poultry infections 
(Kidanermariam et al., 2010; Andino and Hanning, 2015). 
 
It has been widely reported that the incidence of Salmonella infections in various 
species of farm animals is closely linked to the husbandry methods used in the 
farms. It has also been reported that intensive farming methods are favourable to the 
spread of infections, thus leading to an increase in clinical disease. It is due to such 
potential disease risks that countries like Sweden have more stringent rules to control 
foodborne pathogens such as Salmonella (Commission of the European 
Communities, 2000; Kidanermariam et al., 2010). In South Africa, Salmonella 
Enteritidis is a notable disease and measures have been taken by the agricultural 
department to eradicate it. However, it remains a huge burden to both the local and 
the global farming industry (Kidanermariam et al., 2010). 
 
1.14.1 Animal vaccination 
 
A number of Salmonella vaccines are effective for use in poultry, swine and cattle 
(Chiu and Su, 2014). The emphasis placed in vaccination of food animals indicates 
the importance of contaminant free food, thus eliminating human exposure to these 
foodborne pathogens. Salmonella Enteritidis is the most prevalent Salmonella 
serotype in the poultry industry and therefore vaccinating chickens against this 
serotype is essential to ensuring food safety (Alvarado, 2011). In South Africa both 
live and inactivated Salmonella Enteritidis vaccines are licensed for use in efforts to 
reduce contamination of chickens, eggs and chicken products (DAFF and ARC-OVI, 
2000). 
 
1.14.2 Animal farming and antimicrobial resistance 
 
Animals, like humans, acquire bacterial infections that need to be treated through 
antimicrobial therapy and the veterinary requirements for the treatment of these 
bacterial infections with antimicrobials is similar to those in human medicine (Acar 
and R stel, 2001  South African National Veterinary Surveillance and Monitoring 
Programme for Resistance to Antimicrobial Drugs, et al., 2007). However, in 
agriculture the use of antimicrobials is more complex, more especially in food-
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producing animals as it includes treatment, prophylaxis, metaphylaxis and growth 
promotion. This kind of animal treatment regime is essential in order to maintain a 
sustainable and economically feasible animal industry (Acar and R stel, 2001  South 
African National Veterinary Surveillance and Monitoring Programme for Resistance 
to Antimicrobial Drugs, et al., 2007). 
 
However, with the increasing prevalence of antimicrobial-resistant bacteria, there is 
considerable debate on the use of antibiotics in agricultural animals, more especially 
on those raised for human consumption. The main concern is inappropriate use of 
antibiotics in food animals, which could pose a potential threat to human health. This 
is because antimicrobial-resistant microorganisms propagate in these food animals 
and could easily enter the food supply, therefore spreading to humans.  In 2011, the 
World Health Organisation (WHO) reported that the use of fluoroquinolones in food 
animals had resulted in the development of ciprofloxacin-resistant Salmonella, 
Campylobacter and E. coli, which have caused human infections that have proven 
difficult to treat (Teuber, 2001; WHO, 2011; Landers et al., 2012). 
 
Modern day farming often involves intensively managed livestock operations, 
therefore increasing the potential for rapid dissemination of infectious agents from 
animals to humans. This is mainly due to the close proximity in which animals live in 
(feeding through same food channel etc.). Food animals grown in such environments 
usually require assertive infection management strategies, which often involves the 
use of antimicrobial therapy. Although the main goal is to prevent infections in 
animals, thus providing safe meat to humans, the use and administration of 
antimicrobials in the agricultural sector in different parts of the world is concerning. 
Many different classes of antimicrobials are used in the food animal industry, some of 
which are also used in human medicine (e.g. penicillins, cephalosporins, 
sulfonamides etc.). Microorganisms that are resistant to these classes of 
antimicrobials have been isolated from human clinical samples and such resistance 
has been extensively described in literature (Teuber, 2001; Landers et al., 2012). 
 
In 2006, the European Union (EU) banned the use of antimicrobial feed additives 
(AFA) as growth promoters in livestock animals. A study done by Aarestrup (2012) in 
Denmark proved that the elimination of antimicrobials from animal feed had no 
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impact on their meat produce, since Denmark remains the world’s largest exporter of 
pork.  However, such strategies have not been implemented in South Africa (Henton 
et al., 2011; Eagar et al., 2012). 
 
In South Africa, all main classes and types of antimicrobials are authorized for animal 
use and these antimicrobials include those used for growth promotion, most of which 
have been banned from inclusion as food additives in the EU (Henton et al., 2011). 
Approximately 234 antimicrobials have been registered for use in food animals and 
64 (27%) in-feed antimicrobials are registered as stock remedies used for treatment, 
prophylaxis or growth promotion (Eagar et al., 2012). The most commonly sold class 
of antimicrobials included macrolides, tetracyclines, sulfonamides and penicillins, all 
of which are used in human treatment.  
 
In most instances, a small concentration of antimicrobials are used in animal feed 
over long extended periods of time and such a practice can accelerate the 
emergence of antimicrobial-resistant microorganisms in food animals; which in turn 
may lead to human infection with these resistant microorganisms (Eagar et al., 
2012). However, if the quality of industrial farming is improved there will be no need 
for such extensive use of antimicrobials to prevent and combat disease. The farming 
industry needs to improve on hygiene and reduce overcrowding in order to prevent 
rapid spread of disease and consequently reduce the need for prophylactic therapy 
(Garces, 2002; Moyane et al., 2013). 
 
 
1.15 Study objectives 
 
Salmonella Enteritidis is an important pathogen globally and has become a public 
health concern in epidemic areas, particularly in developing countries such as South 
Africa. Poor surveillance in most African countries makes it difficult to ensure proper 
estimates of disease burden and hence the true burden of salmonellosis caused by 
Salmonella Enteritidis has not been established.  
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The exact factors responsible for the Salmonella Enteritidis epidemic are still globally 
unclear (Duchet-Suchaux et al., 1995; Yim et al., 2010). Therefore, efficient 
surveillance structures have to be put in place to prevent massive outbreaks, which 
may take lengthy periods of time to control. Molecular epidemiology is necessary to 
identify the strains of importance that are common in the population. This aids in the 
assignment of proper preventative measures. In the case of zoonotic pathogens such 
as Salmonella Enteritidis, comparison of molecular data gathered from human and 
non-human (such as animal and environmental) isolates may help answer questions 
of transmission and the source of antimicrobial resistance spread (Gruner et al., 
1994; Teuber, 2001; Ranjbar et al., 2014). 
 
To date, no comprehensive molecular epidemiological studies of Salmonella 
Enteritidis strains in South Africa have been carried out.  Therefore, the aim of our 
study is to investigate the molecular epidemiology and relatedness of Salmonella 
Enteritidis strains from humans in Gauteng and Western Cape, South Africa using 
MLVA; secondly to investigate the relatedness of human and non-human Salmonella 
Enteritidis strains in South Africa, using MLVA. Furthermore, we aim to investigate 
the antimicrobial susceptibility profiles of the Salmonella Enteritidis isolates, in order 
to estimate the burden of antimicrobial-resistant Salmonella Enteritidis isolates in 
circulation. 
 
The gradual increase in the prevalence of Salmonella Enteritidis in South Africa over 
recent years emphasizes the need to conduct a molecular epidemiological study. 
This would essentially contribute to monitoring the evolving epidemiological patterns 
of the pathogen. Similarly, this study will allow us to identify and distinguish 
outbreaks from clusters of temporally and geographically proximate cases.  
 
Lastly, we aim to analyse Salmonella Enteritidis outbreaks that occurred during the 
years 2013-2015, in order to ascertain MLVA’s ability to identify outbreak isolates 
and group them into one cluster (MLVA profile). 
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CHAPTER 2: MATERIALS AND METHODS 
 
2.1 Bacterial isolates 
 
 
2.1.1 Human isolates  
 
 
The CED serves as a reference centre for human enteric pathogens. The CED 
participates in the Group for Enteric, Respiratory and Meningeal Surveillance in 
South Africa (GERMS-SA) national laboratory-based surveillance. Microbiology 
laboratories across the country voluntarily submit isolates to the CED, for 
conformation and further characterization (National Institute for Communicable 
Diseases, 2016). The human isolates included in this study were obtained from the 
CED, through the GERMS-SA laboratory-based surveillance. The isolates were 
isolated from various body sites (Appendix A). Each isolate received at the CED was 
assigned an identification number (TCD number) and a unique database reference 
number. The TCD number and unique database reference number were used for 
identification of the patient. The patient details and demographic information obtained 
from the sender (laboratory) form were entered into the CED Microsoft Access 2010 
(Microsoft Corporation, Redmond, USA) database. After 
identification/characterization of the isolates, the results were entered on the CED 
Microsoft Access database, using the TCD number and unique database reference 
number to identify the patient to whom the isolate/s belong. 
At the onset of the study it was anticipated that due to resource constraints, mainly 
time and finances, that only a certain number (approximately 1220) of Salmonella 
Enteritidis isolates would be processed and included for the purpose of this study. 
Gauteng and the Western Cape provinces submit the highest number of Salmonella 
Enteritidis isolates for surveillance purposes to the CED annually. Therefore, to 
eliminate selection bias of isolates and to ensure randomness of selection, all 
Salmonella Enteritidis isolates from the year 2013-2015, present in the CED Access 
database from the Western Cape and Gauteng Province were identified and 
exported onto a Microsoft Excel 2010 (Microsoft Corporation, Redmond, USA) 
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spread-sheet.  Random numbers were assigned to these isolates, using the RAND 
function in Microsoft Excel. The isolates were then selected by sorting them in 
ascending order of random number and selecting the top 1220 isolates. This process 
yielded one duplicate random number and for this reason, this isolate was also 
included, resulting is a total of 1221 (832 from Gauteng and 389 from the Western 
Cape) randomly selected study isolates. 
 
2.1.2 Non-human isolates 
 
A total of 43 non-human isolates from the years 2014-2015 were included in the 
study. Isolates were obtained from the Agricultural Research Council - Onderstepoort 
Veterinary Institute (ARC-OVI) (n = 27), University of Pretoria (n = 7), Deltamune (n = 
3), private suppliers (n = 4) and the Western Cape Veterinary Laboratory (n = 2). The 
isolates were from animals (n = 20), animal environments (n = 2) and some were of 
unknown origin (n = 21). Upon arrival at the CED, the non-human isolates were 
cultured on MAC agar [Diagnostic Media Products, Johannesburg, South Africa (SA)] 
and 5% sheep blood agar (Diagnostic Media Products, Johannesburg, SA) and 
incubated overnight at 37˚C. Following overnight incubation, the plates were 
observed for purity. Culture on 5% sheep blood agar was then harvested using a 
sterile loop and re-suspended in a 10% skimmed-milk (Diagnostic Media Products, 
Johannesburg, SA) suspension and stored at -70°C. 
 
2.1.3  Outbreak isolates  
 
During the years 2013-2015, seven Salmonella Enteritidis outbreaks were reported to 
the CED. These outbreaks occurred within six provinces (Gauteng, KwaZulu-Natal, 
Mpumalanga, Limpopo, Free State and Eastern Cape) in South Africa.  A total of 39 
isolates (one goat meat isolate and 38 human isolates) were received from these 
outbreaks.  The isolates were cultured on MAC agar (Diagnostic Media Products, 
Johannesburg, SA) and 5% sheep blood agar (Diagnostic Media Products, 
Johannesburg, SA) and incubated at 37˚C overnight. Following overnight incubation, 
the plates were observed for purity. Culture on 5% sheep blood agar was then 
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harvested using a sterile loop and re-suspended in a 10% skimmed-milk (Diagnostic 
Media Products, Johannesburg, SA) suspension and stored at -70°C. 
 
 
2.2 Culturing of the bacterial isolates 
 
Isolates were obtained from the CED -70˚C storage freezer. A sterile metal loop 
(heated then cooled) was used to scrap a loop-full of the top part of the frozen 
bacterial culture/skimmed-milk mixture. The contents were plated out on 5% sheep 
blood agar and incubated at 37˚C overnight. 
 
 
2.3 Phenotypic and molecular characterization  
 
2.3.1 Serotyping 
 
Human isolates obtained from 2013-2014 were identified using serotyping. 
Salmonella isolates received at the CED were plated out on 5% sheep blood agar 
and MAC agar. The plates were incubated overnight at 37˚C and the culture was 
observed for purity the following day.  
 
The Kauffman-White-Le Minor scheme (Grimont and Weill, 2007) was used in the 
serotyping of Salmonella to determine the antigenic properties, which are the O 
(somatic) antigens, H (flagellar) antigens and Vi (capsular) antigens. For 
determination of the O phase, a single colony was inoculated onto a tryptose slope 
(Diagnostic Media Products, Johannesburg, SA). The tryptose slope was incubated 
overnight at 37˚C. Following incubation, 1 ml of normal saline was added to the 
tryptose slope and the mixture was vortexed gently to achieve homogeneity. A loop-
full of bacterial suspension was placed on to a clean microscope slide and a drop of 
OMA polyvalent (BioRad, Paris, France) was added onto the microscope slide 
bacterial suspension. The microscope slide was tilted back and forth for 30-60 
seconds (sec), while viewing under good light against a dark background, with the 
aid of an eyepiece. Positive agglutination would be observed for Salmonella 
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positivity. For identification of Salmonella Enteritidis, monovalents 1, 9 and 12 
(Statens Serum Institute, København, Denmark; Davies Diagnostics, Randburg, SA; 
Bioweb, Randburg, SA) would show positive agglutination.  
 
For determination of the H phase, swarm agar was autoclaved for 10 minutes (min) 
and cooled to 52˚C using a water bath. A 20 ml aliquot of cooled swarm agar was 
added into a sterile plate and allowed to solidify before use. A loop-full of culture was 
inoculated by touching the centre surface of the swarm agar. The swarm agar plate 
was incubated in an upright position overnight at 37˚C. Following incubation, 2-3 
drops of H polyvalents antisera (Statens Serum Institute, København, Denmark; 
Davies Diagnostics, Randburg, SA; BioRad, Paris, France; Bioweb, SA) was added 
onto a clean glass slide. Using a sterile loop, a small amount of growth was selected 
from the edge of the swarm agar and a suspension was prepared using the relevant 
polyvalent H antisera. The mix was tilted back and forth for 30-60 sec while viewing 
under good light against a dark background, with the aid of an eyepiece. If 
agglutination was observed, serotyping was repeated using the appropriate 
monovalents. For Salmonella Enteritidis, H phase 1 monovalents (g, m) would show 
positive agglutination and H phase 2 would have no agglutination. Each test isolate 
was performed against a negative control; containing sterile saline. This was to 
ensure that no auto-agglutination was occurring during serotyping. 
 
2.3.2 Molecular identification (real-time PCR) 
 
2.3.2.1 Crude DNA template extraction in preparation for PCR 
 
Real-time PCR was used for the identification of Salmonella Enteritidis isolates 
(human and non-human) from the year 2015. Four-hundred microliters of autoclaved 
TE buffer (Appendix B) was aliquoted into 1.5 ml tubes. Using a sterile loop, bacterial 
culture (loop-full) was harvested from a 5% sheep blood agar plate and was re-
suspended in the 1.5 ml tubes containing TE buffer. The suspension was vortexed 
for 10 sec and placed on a heating block at 95˚C for 25 min. After incubation, the 
tube was vortexed for 10 sec and the solution was centrifuged at 13200 rpm for 3 min 
to pellet the cellular debris. A 20 µl aliquot of the supernatant was transferred into a 
1.5 ml tube with 80 µl of autoclaved TE buffer. The solution was vortexed for 5 sec 
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and centrifuged (13200 rpm) for 10 sec to collect the contents at the bottom of the 
tube. The DNA extracts were stored at -20˚C. 
 
2.3.2.2 Real-time PCR for Salmonella identification  
  
A multiplex real-time PCR was performed using previously described primers 
(Malorny et al., 2004; O'Regan et al., 2008; Park et al., 2008), that were used to 
amplify genes specific for Salmonella species (ttRSBCA gene), Salmonella Enteritidis 
(sdf gene) and Salmonella Typhimurium (STM4497 gene) respectively (Appendix C). 
Each PCR reaction contained a known positive control as well as a non-template 
control. The primer/probe re-suspension, primer probe mix preparation, as well as 
PCR reaction setup are described in Appendix C. The reagents were then added into 
a 96-well reaction plate (BioRad, Hercules, USA) and the PCR reaction was ran on a 
BioRad CFX 96 real-time system (BioRad, Jurong, Singapore). The cycling 
conditions included 1 cycle at 50°C for 2 min, followed by 95°C for 2 min (1 cycle), 
95°C for 15 sec and 60°C for 1 min (25 cycles). Results were viewed after completion 
of the real-time PCR run. A Salmonella Enteritidis positive result contained two 
sigmoidal curves, with Salmonella species in blue and Salmonella Enteritidis in grey 
as depicted in Figure 2.1. For a confident call on a positive result, the sigmoidal 
curves should also be accompanied by a Ct value within the range of 15-25. 
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Figure 2.1 Real-time PCR amplification curve of a Salmonella species (blue) and 
Salmonella Enteritidis (grey) positive result. 
 
 
2.4 MLVA 
 
2.4.1 PCR 
 
The MLVA technique used in this study was as described by Hopkins et al., (2011). A 
multiplex PCR was performed to amplify the five VNTR loci: 
SENTR7_SENTR5_SENTR6_SENTR4_SE-3 (Appendix D), using previously 
extracted DNA (refer to section 2.3.2.1).  The primer mixes, as well as the PCR 
reaction setup are described in Appendix D. The PCR reaction was then performed 
in a DNA thermal cycler (Applied Biosystems, Singapore), with the following run 
conditions; 1 cycle of denaturation at 95°C for 15 min, followed by 35 cycles involving 
an initial step at 94°C for 1 min, annealing at 55°C for 90 sec, polymerization at 72°C 
for 90 sec and final cycle of polymerization at 72°C for 10 min. 
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2.4.2 Processing of PCR products 
 
The PCR products were vortexed for 3 sec at medium speed and 2 µl of the PCR 
product was diluted in 198 µl of autoclaved deionised water. A master mix of 
GeneScan 600 LIZ Standard v2.0 (Applied Biosystems, Foster City, USA) and Hi-Di 
formamide (Life Technologies, London, United Kingdom) was prepared by adding 0.2 
µl and 12 µl of each solution respectively into a 1.5 µl amber tube. A 1 µl aliquot of 
the PCR product dilution was added onto the GeneScan 600 LIZ Standard v2.0 and 
Hi-Di formamide mix. The suspension was vortexed (5 sec), centrifuged (5 sec) at 13 
200 rpm and incubated at 95°C for 3 min. This was followed by immediate incubation 
on ice for 1 min. Each suspension was subsequently transferred onto a 96-well 
barcoded reaction plate (Life Technologies, Beijing, China), sealed and centrifuged to 
remove any air bubbles. 
 
2.4.3 Analysis of PCR products using capillary electrophoresis  
 
The Applied Biosystems 3500 Genetic Analyzer (Applied Biosystems, Tokyo, Japan) 
was used for capillary electrophoresis analysis of the PCR products. The plate 
content (sample) information was assigned to each well and the fragment analysis 
assay was selected as the run method.  
 
2.4.4 MLVA data analysis using GeneMapper software 
 
After capillary electrophoresis analysis, the GeneMapper version 4.1 software 
(Applied Biosystems, Foster City, USA) was used for visual analysis of the sample 
fragment sizes. The software identified each VNTR locus by its distinctive colour 
(SENTR7-blue, SENTR5-blue, SENTR6-black, SENTR4-green and SE-3-green). The 
PCR products (DNA fragments) were automatically sized via comparison to the 
internal size standard. The DNA fragments were automatically allocated to length 
bins and the alleles were assigned based on the bin fragments sizes. The sample 
VNTR allele size pattern (SENTR7_SENTR5_SENTR6_SENTR4_SE-3) could then 
be determined. Successful MLVA for Salmonella Enteritidis strains would produce 
five peaks and validity of test results was assured through the analysis of the 
45 
  
Salmonella Enteritidis reference strain (positive control, TCD736744), with a 
particular expected VNTR allele size pattern (123_292_184_112_306). 
 
 
2.5 BioNumerics analysis of MLVA profiles 
 
The VNTR allele size patterns obtained from MLVA analysis were captured into the 
BioNumerics version 6.5 software (Applied Maths, Sint-Martens-Latem, Belgium) as 
character values. The VNTR allele size numbers were used to assign MLVA profile 
numbers. A single VNTR locus difference between isolates resulted in a new MLVA 
profile being defined (e.g. 123, 268, 184, 112, 318_ MLVA profile 1 and 123, 262, 
184, 112, 318_ MLVA profile 2). To compare differences in the VNTR allele size 
patterns of the isolates, a dendrogram was constructed by the UPGMA method, 
using the categorical coefficient with a 0 tolerance. This dendrogram was used to 
construct a minimum spanning tree (MST), using the MST categorical coefficient. 
 
 
2.6 VNTR diversity measurement  
 
Diversity and degree of polymorphism in each VNTR locus was measured using the 
Simpson’s index of Diversity (D) and the 95% confidence intervals (CI’s) was 
calculated using a free online tool available at the Public Health England (PHE) 
website (http://www.hpa-bioinformatics.org.uk/cgi-bin/DICI/DICI.pl).  
 
 
2.7 Antimicrobial susceptibility 
 
Antimicrobial susceptibility testing against ampicillin, azithromycin, ciprofloxacin, 
ceftriaxone, trimethoprim, tetracycline, sulfamethoxazole and cotrimoxazole was 
conducted using the Etest method.  Salmonella Enteritidis isolates were sub-cultured 
on 5% sheep blood agar plates overnight at 37˚C. Mueller Hinton agar (MHA) 
(Diagnostic Media Products, Johannesburg, SA) and the Etest strips (BioMérieux, 
Paris, France) were placed at room temperature to thaw for 1 hour and 30 min 
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respectively. Using a sterile swab, 3-5 well-isolated colonies, from an overnight 
culture, were selected and transferred to a sterile saline tube to prepare a 0.5 
MacFarland bacterial suspension. The turbidity of the bacterial suspension was thus 
determined using a Microscan Turbidity Meter (Dade Behring, Deerfield, USA). 
Subsequently, a sterile swab was immersed into the bacterial suspension and 
drained on the sides of the saline tube. Using a rotating plate holder (BioMérieux, 
Askim, Sweden), the MHA plates were swabbed in three directional patterns to 
obtain uniform growth. The plates were left to incubate at room temperature for 15 
min. Two Etest strips facing opposite directions were placed in each plate, and the 
plates were then incubated overnight at 37˚C.  
 
The minimum inhibitory concentration (MIC) of each antimicrobial was read based on 
whether the antimicrobial was bactericidal or bacteriostatic. Bactericidal antimicrobial 
MIC was read at the point of complete inhibition of growth and bacteriostatic 
antimicrobial MIC was read at 80% growth inhibition. Interpretation of the result as 
being susceptible, intermediate or resistant was based on the Clinical and Laboratory 
Standards Institute (CLSI) guidelines (CLSI, 2013; CLSI, 2014 and CLSI, 2015) of 
each antimicrobial. Control strains E. coli ATCC 25922 and Klebsiella pneumoniae 
ATCC700608 were cultured every two weeks and upon initial use of a new Etest 
batch to validate the antimicrobial susceptibility test and the Etests strips. Both 
control strains had to be susceptible to all tested antimicrobials, in order to deem the 
Etest and antimicrobial susceptibility test as valid. 
 
 
2.8 Study data analysis 
 
2.8.1 Human isolates 
 
Demographic information (age, gender, province, town etc.) of the human Salmonella 
Enteritidis isolates was obtained from the CED Access database. The demographic 
information was exported onto a Microsoft Excel spread-sheet. The MLVA profiles 
and antimicrobial susceptibility results obtained were also exported to the Microsoft 
Excel spread-sheet. Construction of tables for the results section (Chapter 3) was 
done using Microsoft Excel. The tabled results were stratified by province (Gauteng 
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and Western Cape). Statistical analysis was performed using Epi Info 7 (CDC, 
Atlanta, USA) and testing for statistical significance was performed using Chi-
squared and Fisher’s Exact tests, from which a p-value of <0.05 was taken to be 
statistically significant. 
 
The interpretation of the MST data was based on previously described interpretation 
(Noller et al., 2006). Analysis of the diversity and degree of polymorphism (statistical 
difference) in each locus was based on previously described interpretation of 
Simpson’s diversity index data (Simpson, 1949).  
 
2.8.2 Non-human isolates 
 
Demographic information of the non-human Salmonella Enteritidis isolates was 
obtained from the sender. The information was transferred onto a Microsoft Excel 
spread-sheet. The MLVA profiles and antimicrobial susceptibility results obtained 
were exported to the Microsoft Excel spread-sheet and tables were constructed from 
the data. 
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CHAPTER 3: RESULTS 
 
3.1 Human study population demographic information 
 
3.1.1 Isolate distribution (2013-2015) 
 
During the years of the study (2013-2015), random selection of isolates by Microsoft 
Excel 2010 selected more isolates from Gauteng compared to Western Cape. Of the 
total number of isolates selected from the Gauteng Province during the years 2013-
2015, more isolates were selected in the year 2014, thus accounting for 38% 
(319/832) of the total Gauteng isolates. In Western Cape, more isolates were 
selected in the year 2013, accounting for 41% (159/389) of the total isolates from the 
province. Overall more isolates were selected in the year 2013 (n = 415) and the 
lowest number of isolates were selected in 2015 (n = 400). The overall p-value of the 
total number of isolates selected during the study years was p = 0.42 (Table 3.1). 
 
3.1.2 Age distribution of patients 
 
The median age of patients in Gauteng was 29 years (range, <1-95), with an 
interquartile range (IQR) of 4-47. The age group <1-4 years had the highest number 
of isolates, which accounted for 25% (n = 210) of the total isolates in this province. 
Age group 35-44 years had the second highest number of isolates, thus accounting 
for 13% (n = 110) of the total isolates in Gauteng.  Furthermore, the third highest age 
groups in Gauteng were the 25-34 years (n = 102; 12%) and 5-14 years (n = 96; 
12%) respectively. Age groups with the lowest number of isolates were the 55-64 
years (6%; n = 48) and the 15-24 years (6%; n = 50) (Table 3.1). 
 
The median age of patients in Western Cape was 31 years (range, <1-89), with an 
IQR of 5-50. Age group <1-4 years also accounted for a large number of isolates in 
Western Cape. This age group accounted for 26% (n = 102) of the total number of 
isolates in this province. Age group 35-44 years had the second highest number of 
isolates, thus accounting for 14% (n = 55) of the total isolates in the province. In 
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Western Cape, the third highest age groups were the 45-54 years (n = 46  12%), ≥65 
years (n = 46; 12%) and the 25-34 years (n = 45; 12%) respectively. Age groups with 
the lowest number of isolates were the 55-64 years (7%; n = 80) and the 15-24 years 
(6%; n = 69) (Table 3.1). 
 
Overall the median age was 30 years, with an IQR of 4-48 years, and an age range 
of <1-95 years. The overall age p-value was not statistically significant at p = 0.1. 
Furthermore, age group <1-4 years had the highest number of isolates in the study (n 
= 312; 26%), followed by age group 35-44 years (n = 165; 14%) and age group 25-34 
years (n = 147; 12%) respectively. The overall age distribution p-value was p = 0.91 
(Table 3.1). 
 
3.1.3 Sex (gender) distribution of patients  
 
In Gauteng, females had a higher number of isolates (n = 414: 50%) than males (n = 
404; 49%) and 14 (1%) isolates were of unknown sex. In Western Cape, males had 
higher numbers of isolates (n = 604; 50%) than females 49% (n = 601) and a total of 
16 (1%) isolates were of unknown sex. The overall sex distribution p-value was not 
statistically significant at p = 0.83 (Table 3.1).  
 
3.1.4 Site of isolation 
 
 
The Salmonella Enteritidis isolates included in the study were isolated from various 
parts of the body (Appendix A). The isolates either caused an invasive (isolated from 
sterile site) or a non-invasive (isolated from non-sterile site) infection. A total of 274 
(33%) invasive isolates and 558 (67%) non-invasive isolates were present amongst 
Gauteng isolates. In Western Cape, a total of 142 (37%) invasive isolates and 247 
(63%) non-invasive isolates were selected.  Overall invasive isolates accounted for 
34% (n = 416) of the total isolates. The overall p-value of invasive isolates amongst 
the two provinces (Gauteng and Western Cape) was p = 0.22 (Table 3.1).  
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Table 3.1. Demographic information of the study population.    
Characteristic *GA (n=832) (%) *WC (n=389) (%) Overall (n=1221) (%) 
∆
Overall p-value 
Year     
2013 256 (31) 159 (41) 415 (34) 0.42 
2014 319 (38) 87 (22) 406 (33)  
2015 257 (31) 143 (37) 400 (33)  
Age (years)     
Median (^IQR) 29 (4-47) 31 (5-50) 30 (4-48) 0.1 
Range <1-95 <1-89 <1-95  
Age category     
0-4 210 (25) 102 (26) 312 (26) 0.91 
5-14 96 (12) 39 (10) 135 (10)  
15-24 50 (6) 19 (5) 69 (6)  
25-34 102 (12) 45 (12) 147 (12)  
35-44 110 (13) 55 (14) 165 (14)  
45-54 94 (11) 46 (12) 140 (11)  
55-64 48 (6) 32 (8) 80 (7)  
≥65 83 (10) 46 (12) 130 (10)  
Unknown 38 (5) 5 (1) 43 (4)  
Sex     
Female 414 (50) 187 (48) 601  (49) 0.83 
Male 404 (49) 200 (51) 604 (50)  
Unknown 14 (1) 2 (1) 16 (1)  
Isolate type     
Invasive 274 (33) 142 (37) 416 (34) 0.22 
Non-invasive 558 (67) 247 (63) 805 (66)  
* Province: GA – Gauteng; WC – Western Cape 
∆
 Statistics: Statistical data calculated using the Chi-squared and Fisher’s Exact tests and a p-value <0.05 is statistically significant 
^IQR – Interquartile range 
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3.1.5 Invasive isolates and age distribution 
 
 
Age group <1-4 years, had the highest number of invasive isolates 86/416 (21%), 
followed by age groups 35-44 years (81/416; 19%), 45-44 years (61/416; 15%), 25-
34 years (58/416; 14%) and >65 years (45/416; 11%) (Table 3.2). Age groups 5-14 
years, 15-24 years, 55-64 years and the unknown age group contained less than 
10% invasive isolates. They accounted for 4% (16/416), 5% (20/416), 8% (35/416) 
and 3% (14/416) of the total invasive isolates in the study respectively (Table 3.2). 
 
Table 3.2. Number of invasive isolates per age group. 
 
 
 
3.2 MLVA profiles for human Salmonella Enteritidis isolates 
 
3.2.1 MLVA profile distribution 
 
MLVA was performed on a total of 1221 human Salmonella Enteritidis isolates; 
832/1221 from Gauteng and 389/1221 isolates from the Western Cape. A total of five 
VNTR loci (SENTR7, SENTR5, SENTR6, SENTR4 and SE-3) were included in the 
study. These loci had size variations amongst them, which were used to determine 
strain variability within the isolates.  
 
Age groups Total isolates in age 
group 
Total invasive isolates 
in age group* 
% of invasive isolates in 
age group (*/416x100) 
<1-4 312 86 21 
5-14 135 16 4 
15-24 69 20 5 
25-34 147 58 14 
35-44 165 81 19 
45-54 140 61 15 
55-64 80 35 8 
>64 13 45 11 
Unknown 43 14 3 
Total  1221 416 100 
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A total of 20/1221 (1.6%) isolates had no (0) amplification on one or two loci, with 
lack of amplification occurring on SENTR6 (13/1221; 1%), SE-3 (4/1221; 0.3%) and 
SENTR4 (3/1221; 0.2%). Furthermore, a total of 5/1221 isolates had a locus with two 
alleles. This was observed on SENTR7 (two isolates), SENTR5 (one isolate) and 
SENTR4 (two isolates). The electropherogram of each of the isolates were analysed 
and two peaks were observed in the one respective locus. From the two peaks, the 
peak with the highest frequency was selected as the result. 
 
MLVA profiles were constructed based on single VNTR locus difference between 
isolates. A total of 84 MLVA profiles were determined from 1221 human isolates 
(Appendix D). Overall (2013-2015), MLVA profile 28 (661/1221; 54%) had the largest 
number of isolates, followed by MLVA profile 7 (135/1221; 11%), MLVA profile 22 
(101/1221; 8%) and MLVA profile 21 (68/1221; 6%) respectively (Table 3.3; Table 
3.4; Figure 3.1).  
 
MLVA profile 42 (33/1221) and MLVA profile 41 (24/1221) accounted for 3% and 2% 
of the total isolates respectively (Table 3.3). A total of five MLVA profiles contained 
6-20 isolates per MLVA profile, these MLVA profiles accounted for 3% of the total 
isolates. Furthermore, 73 MLVA profiles consisted of ≤5 isolates per MLVA profile 
and these MLVA profiles accounted for 13% of the total isolates (Figure 3.1). 
Collectively, these 80 MLVA profiles were grouped together and named ‘’other MLVA 
profiles’’ for analysis purposes (Table 3.4).  
 
MLVA profiles with significant numbers of isolates (i.e. predominant MLVA profiles) 
(MLVA profiles 28, 7, 21 and 22) were present in both the Gauteng and Western 
Cape Province. MLVA profile 28 was the most common MLVA profile in both the 
Gauteng and Western Cape Province, accounting for 62% (513/832) and 38% 
(148/389) of the total isolates in the provinces respectively. Of the total number of 
isolates in MLVA profile 28, 78% (513/661) of the isolates were from Gauteng 
Province. MLVA profile 7 accounted for 6% (47/832) of the total isolates in Gauteng. 
In Western Cape, MLVA profile 7 accounted for 22% (87/389) of the total isolates. 
Furthermore, of the total number of isolates in MLVA profile 7, 64% (87/135) of the 
isolates were from the Western Cape Province. MLVA profiles 21 and 22 accounted 
for 6% (48/832) and 9% (78/832) of the total isolates in Gauteng respectively. 
53 
  
Similarly in the Western Cape, MLVA profiles 21 and 22 accounted for 5% (20/389) 
and 6% (23/389) of the total isolates respectively. Furthermore, MLVA profiles 21 
and 22 contained more isolates from Gauteng, which accounted for 71% (48/68) and 
77% (78/101) of the total isolates in these MLVA profiles respectively (Table 3.4; 
Figure 3.2).   
 
Of the 80 smaller MLVA profiles (other MLVA profiles), 50 were present in only one 
province; 28 in Gauteng and 22 in Western Cape. Furthermore, 17/80 MLVA profiles 
contained more isolates from Western Cape, while 8/80 contained more isolates 
from Gauteng and 5/80 contained equal numbers of isolates in both provinces. 
Collectively, these MLVA profiles accounted for 17% (145/832) of the total isolates in 
Gauteng and 29% (111/389) of the total isolates in Western Cape (Table 3.4; Figure 
3.2). 
 
MLVA profiles 28, 21, and 22 were also present in outbreak investigated isolates 
from six provinces in South Africa; namely Gauteng, KwaZulu-Natal, Mpumalanga, 
Limpopo, Free State and Eastern Cape (refer to section 3.6). Isolates that did not 
have a known province were represented in white (only present in the non-human 
isolates; refer to section 3.4) (Figure 3.2). 
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Table 3.3. Example of MLVA profile numbers; MLVA profiles 7, 21, 22 and 28 are predominant. 
SENTR7 SENTR5 SENTR6 SENTR4 SE-3 no: of human isolates 
with MLVA profile (n = 1221) 
MLVA profile number (n = 84) 
132 268 177 112 318 1 1 
132 268 219 112 318 1 2 
132 280 184 112 318 1 3 
132 280 177 119 318 3 4 
132 280 184 112 306 1 5 
132 280 177 112 306 3 6 
132 280 177 119 306 135 7 
132 280 184 119 306 10 8 
132 244 170 112 306 1 9 
123 262 177 126 306 1 10 
123 250 212 140 306 15 11 
123 226 212 126 306 4 12 
123 262 191 112 318 1 18 
123 274 0 112 318 2 19 
123 262 0 112 318 1 20 
123 274 184 112 318 68 21 
123 262 184 112 318 101 22 
123 280 184 112 318 17 23 
123 244 184 112 318 2 24 
123 268 0 112 318 8 27 
123 268 184 112 318 661 28 
123 268 177 112 306 5 29 
132 286 177 119 306 24 41 
132 268 177 119 306 33 42 
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Table 3.4. Predominant MLVA profiles and other MLVA profiles present in the Gauteng and Western Cape Province during the 
years 2013-2015. 
 
*Province: GA – Gauteng; WC – Western Cape  
 
*GA (n = 832) *WC (n = 389) 
Year 
Predominant MLVA profiles 
Other 
MLVA 
profiles 
(%) 
Predominant MLVA profiles 
Other 
MLVA 
profiles 
(%) 
MLVA 7 
(%) 
MLVA 21 
(%) 
MLVA 22 
(%) 
MLVA 28 
(%) MLVA 7 (%) 
MLVA 21 
(%) 
MLVA 22 
(%) MLVA 28 (%) 
2013 (n = 415) 30 (7) 8 (2) 11 (3) 136 (33) 71 (17) 54 (13) 13 (3) 2 (0.5) 44 (10.5) 46 (11) 
2014 (n = 406) 16 (4) 24 (6) 23 (6) 218 (54) 38 (9) 19 (5) 4 (1) 2 (0.5) 45 (11) 17 (4) 
2015 (n = 400) 2 (0.5) 16 (4) 44 (11) 159 (40) 36 (9) 14 (3) 3 (0.5) 19 (5) 59 (15) 48 (12) 
Total (n = 1221)  48 (4) 48 (4) 78 (6) 513 (42) 145 (12) 87 (7) 20 (2) 23 (2) 148 (12) 111 (9) 
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Figure 3.1. MLVA MST for Salmonella Enteritidis isolates from the years 2013-2015, 
drawn using the MLVA profile numbers. 
 
The node (circle) represents the number of isolates in that MLVA profile. MLVA 
profiles are connected by branches and the thickness of the branch indicates how 
many VNTR loci differences are between the connected MLVA profiles (nodes). The 
thick solid lines connect nodes that differ by one VNTR allele and thin solid lines 
connect nodes that differ by two VNTR alleles. The distance between the MLVA 
profiles (nodes) represents the genetic divergence between two neighbouring MLVA 
profiles. 
 
 
MLVA profile 7 
MLVA profile 28 
MLVA profile 21 
MLVA profile 22 
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Figure 3.2. MLVA MST for Salmonella Enteritidis, indicating the provinces included 
on the CED BioNumerics database. 
 
3.2.2 Simpson’s diversity index for Salmonella Enteritidis VNTR loci 
  
Simpson’s diversity index for the five VNTR loci ranged from 0.525 to 0.876. The 
95% confidence intervals (CI) ranged from 0.433 - 0.617 (lowest; SENTR7) to 0.844-
0.908 (highest; SENTR5). The number of alleles found in each locus was also 
calculated from the Public Health England (PHE) website online tool. SENTR5 had 
the highest number of alleles (17), followed by SENTR6 (13) and SENTR4 (8) 
KEYS:  
Gauteng (GA) 
Western Cape (WC) 
Eastern Cape (EC) 
Mpumalanga (MP) 
Limpopo (LP) 
Freestate (FS)             
KwaZulu-Natal (KZN) 
Unknown Province 
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respectively. SENTR7 and SE-3 had the least alleles with seven and four alleles 
each respectively (Table 3.5).  
 
Table 3.5. Simpson's diversity index for the Salmonella Enteritidis five VNTR loci. 
 
Locus *Diversity index (D) ˚95% CI 
∆
Number of alleles (K) 
SENTR7 0.525 0.433 - 0.617 7 
SENTR5 0.876 0.844 - 0.908 17 
SENTR6 0.799 0.745 - 0.853 13 
SENTR4 0.743 0.686 - 0.800 8 
SE3 0.539 0.463 - 0.615 4 
 
*Diversity index (D): measures the variation at each locus based on the number of alleles found at 
that locus from the study population. Ranges from 0.0 (no diversity) to 1.0 (complete diversity). 
˚Confidence interval (CI): Precision of Diversity Index at 95% upper and lower boundaries. 
∆
K: Number of different alleles present at a locus in the study population (Simpson, 1949). 
 
 
3.2.3 Invasive Salmonella Enteritidis isolates and MLVA profiles 
 
Of the predominant MLVA profiles, MLVA profile 28 had the largest number of 
invasive isolates in both provinces (Gauteng and Western Cape). This MLVA profile 
accounted for 37% (153/274) and 13% (55/142) of the total invasive isolates in 
Gauteng and Western Cape respectively. MLVA profile 7 had the second highest 
number of invasive isolates in Western Cape (20%; 29/142), however it had the 
second lowest numbers of invasive isolates in Gauteng (7%; 19/274). MLVA profile 
22 contained the second highest number of invasive isolates in Gauteng, thus 
accounting for 12% (33/274) of the total isolates in the province. Overall, MLVA 
profile 28 accounted for 50% (208/416) of the total number of invasive isolates in this 
study. MLVA profile 7 contained the second highest number of invasive isolates in 
the study (11.5%; 48/416) (Table 3.6). 
 
The other MLVA profiles accounted for 24.5% (101/416) of the total invasive isolates. 
Their largest number of invasive isolates were found in Gauteng Province (53/274), 
were they accounted for 19% of the total invasive isolates in this province. However, 
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in Western Cape these MLVA profiles accounted for a large percentage of 34% 
(48/142) of the total invasive isolates in the province (Table 3.6).  
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Table 3.6. Invasive isolates present in predominant MLVA profiles and the other MLVA profiles from Gauteng and Western Cape. 
 
* Province: GA – Gauteng; WC – Western Cape 
 
 
  *GA invasive isolates (n = 274) *WC invasive isolates (n = 142) 
  Predominant MLVA profiles   Predominant MLVA profiles 
 
Year 
MLVA 7 
(%) 
MLVA 21 
(%) 
MLVA 22 
(%) 
MLVA 28 
(%) 
Other 
MLVA 
profiles 
(%) 
MLVA 7 (%) 
MLVA 21 
(%) 
MLVA 22 
(%) 
MLVA 28 
(%) 
Other 
MLVA 
profiles 
(%) 
2013 (n = 128) 9 (7) 0 3 (2) 34 (26.5) 29 (23) 15 (12) 5 (4) 0 16 (13) 17 (12.5) 
2014 (n = 149) 9 (6) 8 (5) 7 (5) 81 (54) 14 (10) 10 (7) 0 0 14 (9) 6 (4) 
2015 (n = 139) 1 (1) 8 (6) 23 (16) 38 (27) 10 (7) 4 (3) 1 (1) 4 (3) 25 (18) 25 (18) 
Total (n = 416) 19 (4.5) 16 (4) 33 (8) 153 (37) 53 (13) 29 (7) 6 (1) 4 (1) 55 (13) 48 (11.5) 
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3.3 Antimicrobial profiles of human Salmonella Enteritidis 
isolates  
 
 Antimicrobial resistance was tested on eight antimicrobials (ampicillin, trimethoprim, 
cotrimoxazole, sulfamethoxazole, ciprofloxacin, tetracycline, ceftriaxone and 
azithromycin) from six different classes of antimicrobials (penicillins, sulfonamides, 
fluoroquinolones, tetracyclines, cephalosporins and macrolides). All 1221 human 
isolates showed full susceptibility (100%) to azithromycin. Over 98% of isolates 
showed full susceptibility to antimicrobials ampicillin, cotrimoxazole, trimethoprim, 
tetracycline and ceftriaxone respectively (Table 3.7). 
 
Low prevalence of intermediate resistance (≤2%) was observed in 2/8 antimicrobials 
(ampicillin and tetracycline). However, 9% (113/1221) of the isolates were 
intermediately resistant to ciprofloxacin and no intermediate resistance was 
observed for ceftriaxone. Of the 1221 isolates, 29% (348/1221) were resistant to 
sulfamethoxazole. Low prevalence of antimicrobial resistance (≤2%) was observed 
in 5/8 antimicrobials (ampicillin, cotrimoxazole, trimethoprim, tetracycline and 
ceftriaxone). No antimicrobial resistance was observed for ciprofloxacin (Table 3.7).
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Table 3.7. Antimicrobial-susceptibility profiles of human Salmonella Enteritidis isolates (n = 1221). 
 
*Antimicrobial patterns: Antimicrobial patterns observed in the human study population isolates and percentage (%) of isolates that are susceptible, 
intermediately resistant and fully resistant to the tested antimicrobials. 
∆
Antimicrobial beak points: S bp - Susceptible break points; I bp - Intermediate Resistance break points; R bp - Resistant break points  
Antimicrobials *Susceptible (%) ∆S bp (µg/ml) *Intermediate (%) ∆I bp (µg/ml) *Resistant (%) ∆R bp (µg/ml) 
Ampicillin 1201 (98.4) ≤8 2 (0.1) 16 18 (1.5) ≥32 
Cotrimoxazole 1215 (99.5) ≤2 - - 6 (0.5) ≥4 
Trimethoprim 1215 (99.5) ≤8 - - 6 (0.5) ≥16 
Sulfamethoxazole 873 (71) ≤256 - - 348 (29) ≥512 
Ciprofloxacin 1108 (91) ≤0.06 113 (9) 0.12-0.5 0 ≥1 
Tetracycline 1195 (98) ≤4 15 (1) 8 11 (1) ≥16 
Ceftriaxone 1216 (99.5) ≤1 0 2 5 (0.5) ≥4 
Azithromycin 1221(100) ≤16 - - 0 ≥32 
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3.3.1 MLVA profiles and antimicrobial resistance 
 
MLVA profile 28 had the largest number of sulfamethoxazole-resistant isolates. This 
MLVA profile accounted for 58% (202/348) of the total sulfamethoxazole-resistant 
isolates. In the two provinces (Gauteng and Western Cape), MLVA profile 28 
accounted for 65% (162/250) and 41% (40/98) of the total sulfamethoxazole-
resistant isolates in each province respectively. MLVA profile 7 contained the second 
highest number of isolates with sulfamethoxazole resistance, amongst the 
predominant MLVA profiles. Overall, this MLVA profile accounted for 9% (30/ 348) of 
the total sulfamethoxazole-resistant isolates, with its highest number of 
sulfamethoxazole-resistant isolates present in Western Cape (n = 21). Predominant 
MLVA profiles 21 and 22 contained fewer numbers of isolates with sulfamethoxazole 
resistance. The other MLVA profiles had the second highest numbers of 
sulfamethoxazole-resistant isolates in the study, thus accounting for 20% (71/348) of 
the total sulfamethoxazole-resistant isolates. These MLVA profiles accounted for 
16% (40/250) and 32% (31/98) of total sulfamethoxazole-resistant isolates in 
Gauteng and Western Cape respectively (Table 3.8).  
 
MLVA profile 28 had the largest number of ciprofloxacin intermediate resistant 
isolates in both provinces (Gauteng and Western Cape). This MLVA profile 
accounted for 66% (61/92) and 38% (8/21) of the total ciprofloxacin intermediate 
resistant isolates in Gauteng and Western Cape respectively. Overall, MLVA profile 
28 accounted for 61% (69/113) of the total ciprofloxacin intermediate resistant 
isolates in the study. The other predominant MLVA profiles (MLVA profile 7, 21 and 
22) contained fewer ciprofloxacin intermediate resistant isolates compared to MLVA 
profile 28 and the other MLVA profiles. The other MLVA profiles contained the 
second largest ciprofloxacin intermediate resistant isolates. In Gauteng, these MLVA 
profiles accounted for 20% (18/92) of the total ciprofloxacin intermediate resistant 
isolates in the province. Similarly, in Western Cape the other MLVA profiles 
accounted for 28% (6/21) of the total ciprofloxacin intermediate resistant isolates. 
Overall, the other MLVA profiles accounted for 21% (24/113) of the total ciprofloxacin 
intermediate resistant isolates in the study (Table 3.8). 
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Table 3.8. Predominant MLVA profiles and other MLVA profiles with sulfamethoxazole resistance and ciprofloxacin intermediate 
resistance. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*Province: *GA – Gauteng; *WC – Western Cape 
∆
Sulfamethoxazole resistance: *GP (n = 250); * WC (n = 98); * Total isolates (n = 348)  
˚Ciprofloxacin intermediate resistance: *GA (n = 92); * WC (n = 21); * Total isolates (n = 113) 
  
∆Sulfamethoxazole resistance 
MLVA profiles *GA (%) *WC (%) Total isolates (%) 
MLVA 7 9 (4) 21 (21) 30 (9) 
MLVA 21 16 (6) 3 (3) 19 (5.5) 
MLVA 22 23 (9) 3 (3) 26 (7.5) 
MLVA 28 162 (65) 40 (41) 202 (58) 
Other MLVA profiles  40 (16) 31 (32) 71 (20) 
˚Ciprofloxacin  intermediate resistance   
MLVA profiles *GA (%) *WC (%) Total isolates (%) 
MLVA 7 3 (3) 5 (24) 8 (7) 
MLVA 21 7 (8) 1 (5) 8 (7) 
MLVA 22 3 (3) 1 (5) 4 (3) 
MLVA 28 61 (66) 8 (38) 69 (61) 
Other MLVA profiles 18 (20) 6 (28) 24 (21) 
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3.4 Non-human Salmonella Enteritidis isolates 
 
3.4.1 Origin of non-human isolates  
 
During the years 2014-2015, a total of 43 non-human isolates were obtained from 
various sources. Of the 43 non-human isolates, 51% (22/43) were of known origin 
[avian (n = 3), wild animal (n = 2), equine (n = 5), poultry (n = 10) and environmental 
(n = 2)], with various sources. Isolates of unknown origin and source accounted for 
49% (21/43) of the total non-human isolates. Although the origin and source of these 
isolates could not be established, they are from establishments (companies) that 
only work on non-human isolates (Table 3.9). 
 
Table 3.9. Non-human Salmonella Enteritidis isolates included in the study from the 
years 2014-2015. 
 
3.4.2 MLVA profiles for non-human isolates  
 
MLVA was performed on all 43 non-human isolates and ten MLVA profiles (MLVA 
profiles 21, 22, 26, 28, 35, 40, 41, 47, 48 and 49) were generated. MLVA profile 28 
accounted for 35% (15/43) of the total non-human isolates. MLVA profile 26 was the 
second most common MLVA profile accounting for 28% (12/43) of the total isolates. 
Other MLVA profiles (MLVA 21, 22, 35, 40, 41, 47, 48 and 49) accounted for a 
Origin Source Total isolates (n = 43) 
Avian Unknown 3 
Wild animal  Cheetah foetus 1 
Cheetah pyothorax 1 
Equine Horse faeces  3 
Unknown 2 
Poultry Chicken abdominal swab 1 
Chicken egg swab (internal) 1 
Chicken peritonitis 1 
Chicken faeces 1 
Unknown 6 
Environmental Chicken kraal dust 1 
Chicken kraal boot covers  1 
Unknown Unknown 21 
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smaller percentage of isolates. These MLVA profiles accounted for 5%(2/43); 5% 
(2/43); 12% (5/43); 5%(2/43); 2%(1/43); 5%(2/43); 2%(1/43); 2%(1/43) of the total 
isolates respectively (Table 3.10).   
 
Table 3.10. MLVA profiles obtained from the 43 non-human Salmonella Enteritidis 
isolates. 
 
 
 
 
 
 
 
 
 
 
 
 
3.4.3 Antimicrobial profiles of non-human isolates 
 
A total of eight antimicrobial agents (ampicillin, trimethoprim, cotrimoxazole, 
sulfamethoxazole, ciprofloxacin, tetracycline, ceftriaxone and azithromycin) were 
tested on the 43 non-human Salmonella Enteritidis isolates. All isolates were fully 
susceptible (100%) to 5/8 antimicrobials (ampicillin, trimethoprim, cotrimoxazole, 
tetracycline, and azithromycin). A 7% (3/43) and 5% (2/43) intermediate resistance 
was observed for ciprofloxacin and ceftriaxone respectively. Antimicrobial resistance 
amongst non-human isolates was observed for sulfamethoxazole; a total of 10/43 
(23%) isolates were resistant to this antimicrobial (Table 3.11).  
 
MLVA profiles Total isolates in MLVA profile (%) 
MLVA 21 2 (5) 
MLVA 22 2 (5) 
MLVA 26 12 (28) 
MLVA 28 15 (35) 
MLVA 35 5 (12) 
MLVA 40 2 (5) 
MLVA 41 1 (2) 
MLVA 47 2 (5) 
MLVA 48 1 (2) 
MLVA 49 1 (2) 
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Table 3.11. Antimicrobial-susceptibility profiles of non-human Salmonella Enteritidis isolates. 
 
*Antimicrobial patterns: Antimicrobial patterns observed in the non-human study population isolates and percentage (%) of isolates that are susceptible, 
intermediately resistant and fully resistant to the tested antimicrobials. 
∆
Antimicrobial beak points: S bp - Susceptible break points; I bp - Intermediate Resistance break points; R bp - Resistant break points   
Antimicrobials *Susceptible (%) ∆S bp (µg/ml) *Intermediate 
(%) 
∆I bp (µg/ml) *Resistant (%) ∆R bp (µg/ml) 
Ampicillin 43 (100) ≤8 0 16 0 ≥32 
Cotrimoxazole 43 (100) ≤2 - - 0 ≥4 
Trimethoprim 43 (100) ≤8 - - 0 ≥16 
Sulfamethoxazole 33 (77) ≤256 - - 10 (23) ≥512 
Ciprofloxacin 40 (93) ≤0.06 3 (7) 0.12-0.5 0 ≥1 
Tetracycline 43 (100) ≤4 0 8 0 ≥16 
Ceftriaxone 41 (95) ≤1 2 (5) 2 0 ≥4 
Azithromycin 43 (100) ≤16 - - 0 ≥32 
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3.5 Human and non-human Salmonella Enteritidis association  
 
Eight of the ten MLVA profiles present in non-human isolates were also present in 
the human isolates. MLVA profiles 35 and 49 were only found in non-human isolates. 
MLVA profile 28 had the highest number of isolates in both human (n = 661) and 
non-human (n = 15) isolates. MLVA profile 26 contained more non-human isolates (n 
= 12) (Table 3.12; Appendix D).  
 
Table 3.12. Non-human Salmonella Enteritidis isolates found in the same MLVA 
profiles as human Salmonella Enteritidis isolates. 
 
 
3.6 Salmonella Enteritidis outbreaks investigated during the 
study 
 
During the study (2013-2015), seven Salmonella Enteritidis outbreaks were 
investigated from six provinces (Gauteng, KwaZulu-Natal, Mpumalanga, Limpopo, 
Free State and Eastern Cape) in South Africa. All provinces had one outbreak 
episode reported within the years except Mpumalanga, which had two outbreaks; 
one in November 2013 and one in July 2014.  All the outbreaks were associated with 
food poisoning- details on each outbreak are summarized in Appendix E. A total of 
39 isolates associated with the seven reported outbreaks were received at the CED; 
three (KwaZulu-Natal); 17 (Mpumalanga); three (Limpopo); three (Free State); 10 
MLVA profiles Total non-human isolates in 
MLVA profile 
Total human isolates in MLVA 
profile 
MLVA 21 2 68 
MLVA 22 2 101 
MLVA 26 12 6 
MLVA 28 15 661 
MLVA 40 2 9 
MLVA 41 1 24 
MLVA 47 2 1 
MLVA 48 1 3 
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(Eastern Cape) and three (Gauteng). Serotyping was done on all the isolates and 
they were all confirmed to be Salmonella Enteritidis. MLVA was performed and 
dendrogram analysis of the results on BioNumerics showed that within each 
individual outbreak, isolates showed the identical MLVA profile (Figure 3.3).  
 
Among all outbreaks, a total of three MLVA profiles were shown (MLVA profiles 21, 
22 and 28). MLVA profile 21 was present in 3/39 isolates (7.7%) from Gauteng 
Province. MLVA profile 22 was present in 6/39 (15.4%) isolates; three isolates from 
the KwaZulu-Natal outbreak and three isolates from the 2013 Mpumalanga outbreak. 
MLVA profile 28 was the most predominant MLVA profile, accounting for 77% 
(30/39) of the overall outbreak isolates. This profile contained three isolates from 
Limpopo, 14 isolates from Mpumalanga (2014), three isolates from Free State and 
10 isolates from Eastern Cape Province. A MST of the outbreak isolates is shown in 
Figure 3.2, with different colour keys for each province. 
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Figure 3.3. Dendrogram of the Salmonella Enteritidis outbreak isolates from the 
years 2013-2015. MLVA profile 21 is highlighted in purple, MLVA profile 28 in green 
and MLVA profile 22 in bronze. 
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CHAPTER 4: DISCUSSION 
 
 
4.1 Human Salmonella Enteritidis study population 
 
4.1.1 Isolate distribution 
 
The random selection of isolates from Microsoft Excel spread-sheet selected more 
isolates from Gauteng (n = 832) than Western Cape (n = 389). This was because, 
during the years 2013-2015, the CED received more isolates from Gauteng 
compared to Western Cape, and the reason for this is unknown.  
 
However, despite variations in the number of isolates selected from the two 
provinces, the overall number of isolates selected throughout the three years (2013-
2015) was closely similar. This was further supported by the p-value obtained (p = 
0.42), which showed no statistical difference amongst the years.   
 
4.1.2  Age distribution 
 
Analysis of age distribution amongst the two provinces revealed numerous 
similarities from the age median (Gauteng, 29 years; Western Cape, 31 years), IQR 
(Gauteng, 4-47; Western Cape, 5-50) and age ranges (Gauteng, <1-95; Western 
Cape, <1-89). Overall, the study population median age was 30 years, with an IQR 
of 4-48 and an age range of <1-95. This suggested that the study population mainly 
consisted of adults (median), and that 50% of our study population falls between the 
ages of 4-48 years (IQR). An age range of <1-95 years, showed that Salmonella 
Enteritidis infections had affected all age groups, from the very young to the very old. 
This finding is consistent with global reports of Salmonella Enteritidis infections 
(WHO and FAO, 2002). The overall age distribution gave a p-value of p = 0.91, thus 
indicating that there was no statistical difference in age distribution amongst the two 
provinces. Despite this p-value, in-depth analysis of the age groups showed 
reportable variations. 
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In-depth analysis of the age groups in each province respectively, showed that age 
group <1-4 years had the highest number of isolates in both provinces (Gauteng, n = 
210; Western Cape, n = 102), thus accounting for 25% (Gauteng) and 26% (Western 
Cape) of the total isolates in each province respectively. Overall, this age group 
accounted for the highest number of isolates in the study (26%; 312/1221). Similarly, 
the second highest age group in both provinces was the 35-44 years (Gauteng, n = 
110; Western Cape, n = 55), which accounted for 13% (Gauteng) and 14% (Western 
Cape) of the total isolates in each province respectively. Overall, this age group also 
accounted for the second highest number of isolates in the study (13.5%; 165/1221). 
 
The general global observation of Salmonella infections amongst the different age 
groups is that infection incidence rates peak in children and the elderly (bimodal 
distribution) (WHO and FAO, 2002). However in Africa, several studies have 
described a bimodal distribution, different to that seen in other parts of the world. 
This bimodal distribution has its initial peak in the <1-4 years age group (children) 
and the second peak occurring in the adult age groups (Ao et al., 2015). 
 
Globally, the <1-4 years are the mostly commonly affected age group in terms of 
diarrhoeal disease and despite global efforts to reduce the spread, diarrhoea 
remains the 2nd leading cause of death amongst children under five years of age 
(Morpeth et al., 2009; Liu et al., 2012). This population age group is more 
susceptible to infection by Salmonella and other foodborne pathogens, because their 
immune system is not fully developed (Dropulic and Lederman, 2009). 
 
In Africa, several studies have described the burden of NTS amongst young children 
under the age of five years (Gordon et al., 2008; Morpeth et al., 2009; Sigauque et 
al., 2009). In a study done by Mandomando et al. (2009) on invasive NTS amongst 
Mozambican children, Salmonella Enteritidis was the second most common 
Salmonella found in children (Salmonella Typhimurium most common) with an 
incidence rate of 28.9 cases⁄ 105 child-years and with an incidence rate of 108.6 
cases⁄ 105 child-years in infants. This shows the severity of Salmonella Enteritidis 
infections amongst young children in Africa.  
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The burden of disease observed amongst the <1-4 year age group in this study 
correspond with the global observation, and highlights the need for continual 
improvement of strategies to reduce the burden of foodborne diseases, particularly 
amongst young children. 
 
The second highest age group in the study was the 35-44 years (adults) and this 
trend is not common globally. This peak may be attributed to HIV infection; however, 
since the HIV status of the study population is unknown, we cannot say for certain. 
Nonetheless, previously published data from Africa has described the strong 
association between NTS infection and HIV infection, and this association has been 
noted to be strongest amongst the adult age group (Morpeth et al., 2009). Individuals 
with HIV are prone to infection and recurrent infections by enteric bacterial 
pathogens such as Salmonella Enteritidis (WHO and FAO, 2002; Feasey et al., 
2016). 
 
South Africa has a high prevalence of HIV and according to the Statistics South 
Africa 2015 mid-year population estimates, an estimated 6.19 million (6.19 million 
/54.96 million; 11.2%) South Africans are HIV infected (Statistics South Africa, 2015). 
Adults between the ages of 15-49 are the most affected, accounting for 16.6% of the 
total population in this age group.  
 
In this study we also observed large numbers of isolates within age groups 25-34 
years (147/1221; 12%) and 45-54 years (140/1221; 11%). These two age groups 
also contain a large portion of the HIV infected population, thus possibly supporting 
its (HIV) role in the prevalence of Salmonella Enteritidis amongst these age groups, 
as reported in most African literature (Gordon, 2009; Morpeth et al., 2009). This is 
further suggested by the overall IQR (4-48 years), which includes a large portion of 
the HIV infected population.  
 
Children over the age of 5 years (5-14 years) were also significantly affected, thus 
accounting for 10% (n = 135) of the study population. This notable prevalence rate 
amongst the 5-14 years age group has been described in previous literature 
(Khanum et al., 2006). Possible causes of infection amongst the 5-14 years age 
group include; lack of access to clean drinking water and exposure to contaminated 
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food items that are available in open-air school cafeteria (Asghar et al., 2002; 
Khanum et al., 2006). However, there was a notable reduction in the number of 
cases observed in this age group compared to the <1-4 years age group. This 
reduction may be due to further development of immunity and the production of 
efficient antibodies necessary to disable the bacterium (MacLennan et al., 2008). 
This advanced immunity may also be responsible for the lower numbers of isolates 
(overall) amongst the 15-24 years age group.  
 
Individuals in the >65 years age group also had a notable prevalence rate 
(130/1221; 10%), which has been extensively described in literature globally. Elderly 
individuals are immune compromised, this is due to age-related deterioration of their 
immune system and co-morbidities (such as heart disease, malignancies), which 
result in increased proneness to infection. (WHO and FAO, 2002  Lund and O’Brien, 
2011; Chen et al., 2012).  
 
Age group 55-64 years had lower numbers of isolates (n = 80; 7%) compared to the 
>65 years. This may be due to the fact that this age group falls outside the HIV 
infected population age bracket (lower HIV infection), and that these individuals may 
still have a considerably efficient immune system, compared to the >65 years.  
 
Overall in this study, children (<1-4 years) and adults within the HIV infected 
population age groups (25-34 years, 35-44 years and 45-54 years) are at higher risk 
of Salmonella Enteritidis infection.  
 
4.1.3 Gender distribution  
 
Overall, the gender distribution in this study showed no statistical difference (p = 
0.83) amongst the two sexes. Several studies with different views about NTS and 
gender association have been published. Some studies report an infection ratio of 
1:1 for both male and female and others describe males being more susceptible to 
infection than women and vice versa (WHO and FAO, 2002). In this study the former 
is true; the number of males and females infected by Salmonella Enteritidis was 
relatively equal.  
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4.1.4 Invasive Salmonella Enteritidis isolates 
 
The Gauteng Province contained the largest number of invasive isolates (n = 274; 
33%), and this was expected since Gauteng had more isolates compared to the 
Western Cape. However, the Western Cape Province contained a larger percentage 
of invasive isolates (37%; n = 142). The cause of increased invasive isolates in 
Western Cape is unclear, and may not necessarily be a true reflection of invasive 
Salmonella Enteritidis prevalence in Western Cape. Furthermore, the overall p value 
(p = 0.22), indicates that there is no statistical significance amongst the two 
provinces invasive isolates. 
 
The overall percentage of invasive isolates obtained in this study is 34% (416/1221). 
This percentage is highly notable and concerning since deaths from invasive 
Salmonella infections are common in Africa (Vugia et al., 2004; Feasey et al., 2012; 
Ao et al., 2015). Furthermore in Africa, invasive Salmonella Enteritidis is often 
associated with infants (<3 years) and immune-compromised people, such as those 
with HIV; which are the most vulnerable populations within society (Morpeth et al., 
2009).  
 
In this study we observed that young children (<1-4 years), the elderly and people 
within the adult age groups had a higher percentage of invasive disease (Table 3.2). 
Invasive disease amongst the young children and the elderly may be due to an 
under developed immune system (children) and an age related weakened immune 
system (elderly). Although we cannot definitively identify HIV infection as the 
contributing factor for invasive disease within the adult age groups (HIV status of the 
study population is unknown), such a phenomenon has been extensively described 
in previous literature.  
 
Despite the correlation of our findings with previously published data, the exact 
cause of invasive disease amongst 34% of our human study population is unknown. 
However, the host’s susceptibility to infection also plays an important role. This is 
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evident amongst the high risk groups, who have poor immune function, which may 
make them prone to invasive Salmonella Enteritidis infection (Feasey et al., 2012; 
Langridge et al., 2012 and Feasey et al., 2016). 
 
On the other hand, the Salmonella Enteritidis isolates in this study were not analysed 
for any enhanced virulence traits, thus we cannot rule out increased virulence within 
these isolates. Further studies would need to be carried out to investigate the 
presence of such traits. 
 
Furthermore, lack of access to clean water and other socioeconomic problems play 
an important role in increased exposure to Salmonella Enteritidis and the 
development of invasive disease. Therefore, emphasis needs to be put into providing 
clean water and sanitation, in order to reduce exposure to Salmonella, particularly 
amongst children, the elderly and immune-compromised individuals (Langridge et al., 
2012).  
 
 
4.2 MLVA 
 
4.2.1 The Salmonella Enteritidis VNTR loci 
 
A total of five VNTR loci (SENTR7, SENTR5, SENTR6, SENTR4 and SE-3) 
previously described by Malorny et al., (2008) and Hopkins et al., (2011) were used 
in the study. These loci were shown to have consistent sequence length and 
diversity. Malorny et al., (2008) first reported on these five VNTR loci, along with four 
other VNTR loci (SENTR1, SENTR2, SENTR3 and SE-7). In their study SENTR7, 
SENTR5, SENTR6, SENTR4 and SE-3 had a higher Nei’s diversity index (diversity 
index similar to the Simpson’s diversity index, refer to section 4.5) compared to the 
other four VNTR loci, thus allowing for better discrimination Salmonella Enteritidis 
strains.  
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4.2.2 Lack of amplification on VNTR loci 
 
In this study, lack of amplification was noted on VNTR loci SENTR6 (n = 13), 
SENTR4 (n = 3) and SE-3 (n = 4), with SENTR6 having the most lack of 
amplification. The lack of amplification at a particular VNTR locus was logged as “0” 
in the MLVA profile and the “0” was used as a unique feature in the definition of 
MLVA profiles (Appendix D). 
 
A similar event was observed by Haguenoer et al., (2011), who found that certain 
isolates within their study lacked amplification at a particular VNTR locus. The locus 
was part of a genomic island and the initial primer pair only targeted the border 
regions of the genomic island. Haguenoer et al., (2011) designed a second primer 
pair which targeted flanking regions beyond the borders of the genomic island. 
Failed amplification with the second primer pair confirmed the absence of this locus 
in some of the isolates. Although Haguenoer et al., (2011) confirmed the cause for 
lack of amplification in their isolates; lack of amplification is not only attributed to the 
absence of the VNTR locus, but it may also be due to modification of the region in 
which the primer binds (Haguenoer et al., 2011). However, in our study lack of 
amplification in some of the isolates cannot be confirmed as being due to the 
absence or modification of the VNTR locus, since no further investigation of these 
possibilities was performed.  
 
4.2.3 Electropherogram with double peaks at a VNTR locus 
 
Electropherogram analysis (GeneMapper analysis) of each MLVA PCR product, 
revealed five isolates with double peaks at a VNTR locus. This occurred in loci 
SENTR7 (n = 2); SENTR5 (n = 1) and SENTR4 (n = 2). The presence of double 
peaks at a locus may indicate that each bacterium in the culture has two copies of 
the locus in question. Alternatively, this may mean that each bacterium may have 
one copy of the locus, but that more than one strain is present in the culture 
population and so contributing to the multiple alleles sizes.   
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In order to verify the double peaks, the isolates were plated out for single colonies 
and two colonies from each plate were analysed individually by MLVA. The double 
peaks were reproducible on all the isolates. Observation of all the electropherograms 
generated from each of the isolates, revealed differences in the two peak’s 
fluorescence intensities. One of the peaks consistently had higher fluorescence 
intensity compared to its counterpart. According to Nadon et al., (2013), the peak 
that consistently has higher fluorescence intensity is then taken as the main allele 
(true result) and the other peak should be ignored. The same analogy was used in 
this study, for all isolates with double peaks at a locus. 
 
4.2.4 Association of bacterial divergence and MLVA profiles 
 
Noller et al., (2006), defined isolates with no more than a single VNTR difference 
occurring between all loci as being of the same lineage, the same analogy was used 
in this study. In this study, 72 MLVA profiles were observed as belonging to the 
same lineage and 14 MLVA profiles showed close relation (two loci difference) to the 
former. The most predominant MLVA profiles (MLVA profile 28, 7, 22, and 21) 
belong to the same lineage and therefore are closely related to each other (Figure 
3.1).  
 
The distance between two MLVA profiles indicates the differences that have 
occurred between the two MLVA profiles (genetic divergence). Based on this, MLVA 
profile 28 is closely related to MLVA profile 21 and 22, thus indicating that little 
variation has occurred between these MLVA profiles (very similar). The distance 
between MLVA profile 28, 21 and 22 to MLVA profile 7 is large, thus indicating that 
major changes have occurred between them (high genetic divergence).  
 
4.2.5 Association of environmental factors and MLVA profiles  
 
According to Dawson (2012) diversification within a lineage often results from 
interactions between the intrinsic biological limitations of organisms and the extrinsic 
environmental factors. In order to better understand the evolution of resident 
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lineages within a particular environmental setting, the demographic patterns of the 
co-existing populations need to be analysed in context to the history of the region 
(Dawson, 2012). Many studies have described environmental variation as a common 
factor in the influence of bacterial lineage diversity (Avitia et al., 2014). Genetic 
divergence within a bacterial lineage that is attributed to environmental factors may 
have occurred in our study and this may be further supported by the dominance of 
certain MLVA profiles in specific provinces. MLVA profiles 28, 22 and 21 are closely 
related to one another and seem to be more predominant in the Gauteng province. 
Furthermore, the smaller MLVA profiles that are closely related to these three MLVA 
profiles are largely present in Gauteng than in Western Cape. Similarly, MLVA profile 
7 is more predominant in Western Cape and the smaller MLVA profiles closely 
related to MLVA profile 7 are mainly present in Western Cape (Figure 3.2).  
 
4.2.6 MLVA clusters  
 
In studies done by Murphy et al., (2008) and Cho et al., (2008), arrangement of 
MLVA profiles into clusters was based on the number of VNTR loci differences 
between the MLVA profiles. They reported that MLVA profiles with three or more 
VNTR loci differences (nodes connected by dotted lines) were genetically distant and 
would therefore not fall into the same cluster as MLVA profiles with one-two VNTR 
loci differences. In our study, two VNTR loci differences were observed amongst the 
MLVA profiles, therefore only a single MLVA cluster was obtained in the study. This 
is an indication of clonality amongst Salmonella Enteritidis strains in the two 
provinces, which may indicate that the strains originate from a single Salmonella 
Enteritidis ancestor (Cho et al., 2008; Murphy et al., 2008). Such clonality may be the 
reason for such close relations amongst the MLVA profiles obtained in this study. A 
similar finding was observed in Iran, wherein six closely related MLVA profiles were 
identified in the study and the high clonality of the Iranian Salmonella Enteritidis 
isolates was deemed as the cause for the close relation amongst the MLVA profiles 
(Acton, 2013). An extensive phylogenetic analysis needs to be conducted on our 
Salmonella Enteritidis isolates to confirm that they share a common ancestor. 
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4.2.7 MLVA profile homogeneity  
 
The human isolates included in this study were from only 2/9 provinces in South 
Africa. The Western Cape and Gauteng province are the most urbanised cities in the 
country, a large number of people from different provinces in the country, as well as 
different countries in Africa are found largely in these two provinces (Statistics South 
Africa, 2015). Therefore, these two provinces allow us to get a general view of the 
Salmonella Enteritidis strains circulating in the country. The high homogeneity of 
these isolates may be indicative of the stains circulating in the country. A study by 
Campioni et al. (2013) on the observation of the Salmonella Enteritidis strains 
circulating in Brazil, found that there was high genetic homogeneity in the Salmonella 
Enteritidis strains found in both humans and animals in Brazil. Due to such high 
strain homogeneity, they were able to identify the introduction of a new Salmonella 
Enteritidis strain, which was highly diverse compared to the native strains. Further 
analysis of the strain revealed that it originated from North America. A similar 
surveillance can be initiated in South Africa using MLVA and it can be useful in the 
identification of new strains associated with foreign travels and potential outbreaks 
caused by the newly introduced strains.  
 
4.2.8 Discriminatory power of MLVA (Simpson’s diversity index) 
 
The Simpson’s diversity index (D) calculates diversity within each locus and it also 
measures the probability that two epidemiologically unrelated isolates will be 
characterized as being different. This enables observation of VNTR polymorphism 
(Boxrud et al., 2007). A VNTR locus with a higher D value (value closer to one), 
shows that it is highly diverse and could be helpful in differentiating isolates from the 
same environment (geographical area), as well as give greater discrimination for 
epidemiologically unrelated strains. In our study SENTR4, SENTR5 and SENTR6 
had D values between 0.7-0.9, and SENTR7 and SE3 had D values of 0.525 and 
0.539 respectively. Therefore, SENTR4, SENTR5 and SENTR6 have greater 
polymorphism than SENTR7 and SE3.  SENTR7 and SE3 are less variable and are 
the loci that define the MLVA profile. These loci (SENTR7 and SE3) serve as 
molecular clocks and are predominantly useful in phylogenetic analysis of isolates 
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that are more geographically dispersed (Boxrud et al., 2007; Haguenoer et al., 2011; 
Hopkins et al., 2011). 
 
In our study, SENTR5 had the highest number of alleles (17 alleles), followed by 
SENTR6 with 13 alleles and SENTR 4 with eight alleles. SENTR7 and SE-3 had the 
least numbers of alleles, with seven and four respectively. These findings are 
comparable to those found by Malorny et al., (2008), whereby SENTR6 had the 
highest number of alleles (11 alleles) followed by SENTR5 (10 alleles) and SENTR4 
with seven alleles. Malorny et al., (2008) also observed that SENTR7 and SE-3 had 
the least number of alleles, with three each.  
 
Several studies have compared both MLVA and PFGE using Simpson’s diversity 
index and most of these studies have shown that MLVA has higher discriminatory 
power than PFGE. Although we did not compare the two molecular techniques, 
literature has reported on MLVA’s higher discriminatory power and the incorporation 
of VNTR loci with different Simpson’s diversity indexes makes it possible to 
discriminate between closely related and distantly related Salmonella Enteritidis 
strains (Boxrud et al., 2007; Hopkins et al., 2011; Haguenoer et al., 2011).  
 
4.2.9 MLVA profiles and invasive Salmonella Enteritidis isolates 
  
The association of MLVA profiles and invasive isolates has not been reported in 
literature. This may be due to the fact that most countries do not use MLVA as a 
standard typing method. However, numerous studies have described the association 
of certain Salmonella Enteritidis phage types with invasive disease. Salmonella 
Enteritidis PT4 has been described as the most common and most virulent 
Salmonella Enteritidis phage type and studies have shown the association of this 
phage type with invasive disease in both humans and animals (Poppe et al., 1993; 
Indar-Harrinauth et al., 2001). The same could be possible using MLVA as a 
standard typing method. 
 
MLVA profile 28 had the highest number of invasive isolates in the study (208/416). 
This is least surprising since it accounts for majority of the isolates in the study (n = 
661). However, our data also showed that the other MLVA profiles contained large 
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numbers of invasive isolates (101/416). This is indicative of the fact that invasive 
isolates are not confined to one particular MLVA profile, but that even the smaller 
MLVA profiles can contain invasive isolates. More so, the possibility of increased 
virulence within these MLVA profiles cannot be disregarded. Further genotypic 
analysis of the invasive isolates present in these MLVA profiles is necessary. 
In this study, we were able to show that not only one MLVA profile is associated with 
invasive Salmonella Enteritidis infection. However, our data does not indicate if there 
is any clinical significance on the association of MLVA profiles and invasive isolates. 
The establishment of such a trend may assist in the advancement of molecular 
epidemiological surveillance.  
 
 
4.3 Antimicrobial susceptibility profiles of human Salmonella 
Enteritidis isolates 
 
Over the past few decades, many reports have described the increase in resistance 
of NTS serotypes to medically important antimicrobial agents. Antimicrobial 
resistance in NTS serotypes is a global challenge, although the resistance rate 
varies amongst different serotypes and different antimicrobials. Numerous reports 
from different parts of the world have shown that Salmonella Enteritidis is still 
relatively susceptible to most antimicrobial agents compared to other serotypes (Su 
et al., 2004; CDC, 2013; Chiu and Su, 2014). However, isolated studies from various 
parts of the world have shown a major increase in resistance of Salmonella 
Enteritidis isolates (Morpeth et al., 2009; Jiayong et al., 2015).  
 
In this study, 55.4% (677/1221) of the total human isolates were fully susceptible to 
all antimicrobials tested (section 3.3). Low prevalence of resistance was observed in 
7/8 antimicrobials; however, high prevalence of resistance was observed for 
sulfamethoxazole, with 29% (n = 348) of the isolates having resistance to this 
antimicrobial. A similar finding was observed by Smith et al., (2014) in a study, which 
compared Salmonella Enteritidis isolates from humans and wild animals in South 
Africa. Of the 196 humans isolates included in their study, 43% were resistant to 
sulfamethoxazole.  
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There is limited data on sulfamethoxazole resistance in human Salmonella Enteritidis 
isolates. This is because sulfamethoxazole is generally used in combination with 
trimethoprim (cotrimoxazole) in the treatment of human infections. Many publications 
have described resistance of Salmonella isolates to cotrimoxazole, however in this 
study cotrimoxazole resistance was very minimal, with <1% of the isolates showing 
resistance to this drug.  In most African settings, sulfamethoxazole (sometimes in 
combination with trimethoprim as cotrimoxazole) is used as a prophylactic drug in 
HIV/Aids patients as a means to prevent life threatening opportunistic infections. This 
use of sulfamethoxazole has been shown to reduce mortality and morbidity in people 
with HIV (Hamer and Gill, 2008). This prophylactic use of sulfonamides still 
continues today in South Africa and in many other parts of Africa (Sibanda et al., 
2011; National Department of Health South Africa, 2015). Such continual exposure 
to antimicrobials has been shown to lead to the selection of resistant bacterial strains 
(Eagar et al., 2012; National Department of Health, 2015). Thus, it is possible that 
pathogens such as Salmonella Enteritidis may have gained resistance against 
sulfamethoxazole due to such constant exposure.  
 
Another contributor of high sulfamethoxazole resistance may be its use in the 
agricultural sector. Several studies have described sulfamethoxazole’s use in animal 
prophylaxis (Kumar et al., 2005; Eagar et al., 2012).  Although we are unable to pin 
point the exact cause of increased sulfamethoxazole resistance in our isolates. The 
excessive use of sulfamethoxazole in the farming sector may be playing a role in the 
emergence of sulfamethoxazole-resistant isolates (refer to section 1.14.2 and 
section 4.5).  
 
In this study, 9% (113/1221) of human isolates showed intermediate resistance to 
ciprofloxacin. Ciprofloxacin is an important antimicrobial used in the treatment of 
numerous bacterial infections including extra-intestinal Salmonella infections (Chiu 
and Su, 2014).  Numerous studies from different parts of the world (including Africa), 
have described ciprofloxacin-resistant Salmonella Typhi isolates (Kariuki et al., 2010; 
Medalla et al., 2011; Rahman et al., 2014; Al-Emran et al., 2016). Such infections 
have led to clinical treatment failures with dire consequences. However, there is 
limited data on reduced susceptibility of NTS (such as Salmonella Enteritidis) to 
ciprofloxacin.  A study by Eibach et al. (2016) in Ghana, reported on reduced 
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susceptibility of Salmonella Enteritidis isolates (10/19; 53%) to ciprofloxacin. Further 
genotypic analysis of the isolates revealed mutations in the gyrA gene, which confers 
low-level resistance to ciprofloxacin.  
 
In Africa, there are limited reports on the amount of ciprofloxacin prescribed in health 
care facilities. Thus, we are unable to identify the exact cause of ciprofloxacin 
intermediate resistance amongst our isolates. However, in 2011 the WHO reported 
that the use of fluoroquinolones in the food animal industry was a major contributor 
to the emergence of ciprofloxacin-resistant Salmonella, Campylobacter and E. coli. 
This had resulted in human infections that had proven difficult to treat (Teuber, 2001; 
WHO, 2011; Landers et al., 2012); thus indicating the impact the food animal 
industry has on the emergence of antimicrobial resistance.   
 
Although we cannot confirm the exact cause of ciprofloxacin intermediate resistance, 
it is however possible that the isolates may have acquired resistance genes through 
any of the previously described gene acquisition mechanisms (section 1.11.2). 
Further genotypic studies have to be done on our ciprofloxacin intermediate resistant 
isolates in order to conclude the presence or absence of resistance genes. On the 
other hand, we also recognize that limited data regarding the use of ciprofloxacin in 
African health care settings (public and private), may limit our understanding of the 
role ciprofloxacin use in these health care facilities plays in the emergence of 
antimicrobial resistance.  
 
4.3.1 MLVA profiles and antimicrobial resistance 
 
The highest sulfamethoxazole resistance was found amongst the Gauteng isolates. 
This was expected, due to the large number of isolates selected from Gauteng. 
Sulfamethoxazole resistance was present in both the predominant MLVA profiles 
and the other MLVA profiles, thus showing that different strains (found in various 
MLVA profiles) have mechanisms that confer for sulfamethoxazole resistance.  
 
Of the predominant MLVA profiles, MLVA profile 28 had the highest number of 
sulfamethoxazole-resistant isolates in this study, thus accounting for 58% (202/348) 
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of the total sulfamethoxazole-resistant isolates. This is expected since majority of the 
isolates consist of this MLVA profile.  
 
Further analysis of the MLVA profiles (MST analysis) seems to indicate that 
resistance mechanisms may have been acquired individually within the different 
MLVA profiles. This is because other MLVA profiles that are closely related to MLVA 
profiles with sulfamethoxazole-resistant isolates, show full susceptibility to 
sulfamethoxazole. This means resistance mechanisms could not have been passed 
down during strain diversity. Environmental pressures may have played a huge role 
in the acquisition of these resistant genes (Dawson, 2012). Furthermore, majority of 
the resistance mechanisms are found in non-chromosomal DNA, thus making it 
highly plausible that the isolates found in these MLVA profiles obtained them 
(resistance genes) after strain diversification (Hamer and Gill, 2008). However, 
further molecular investigation needs to be carried out in order to prove this 
hypothesis.  
 
Similarly, higher ciprofloxacin intermediate resistance was observed amongst 
Gauteng isolates. MLVA profile 28 (61%; 69/113) had the highest number of isolates 
with ciprofloxacin intermediate resistance. Observation of the MST shows a picture 
similar to that observed in sulfamethoxazole-resistant isolates. Thus, emphasizing 
the role environmental pressures play in the acquisition of antimicrobial resistance 
mechanisms.  
 
In this study, we observed that antimicrobial testing along with MLVA can potentially 
be used as a surveillance tool which may assist in identifying antimicrobial pattern 
changes in Salmonella Enteritidis isolates present within different MLVA profiles (i.e. 
acquisition of resistance genes that were not seen before in that MLVA profile). This 
is due to the fact that other MLVA profiles in the study contained isolates that were 
resistant to more than one antimicrobial. This may help in identifying Salmonella 
Enteritidis outbreak strains that belong to MLVA profiles with certain antimicrobial 
resistance patterns.  
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4.4 Non-human Salmonella Enteritidis isolates 
 
A total of 43 non-human isolates from different origins (poultry, wild animal, equine, 
avian and environmental), collected from various parts of the country were included 
in the study. Disappointingly, 49% (21/43) of our non-human isolates were of 
unknown origin (and source) and lacked demographic data. The isolates were 
accepted at the CED and included in the study as non-human isolates due to the fact 
that they were obtained from known veterinary laboratories.  
 
Obtaining isolates from private veterinary laboratories was difficult, because the 
laboratories have signed confidentiality agreements with their customers (usually 
food animal producers), which prevents them from disclosing any findings with any 
third party. In situations where isolates were obtained, some laboratories would 
withhold valuable information about the isolates such as their origin, collection date 
and place of collection (province and town), in fear of possible linking of data to their 
clients. Furthermore, laboratories may also be reluctant to give isolates or further 
details about the isolates, more especially in the case of Salmonella Enteritidis, since 
it is a controlled pathogen in South African agricultural sector. All these aspects 
resulted in very few non-human isolates being included in the study.  
 
Despite the poor numbers received, the non-human isolates collected were from 
diverse origins such as agricultural animals, wild animals, domestic animals and 
animal environments. We hoped that this isolate diversity would enable us to 
observe Salmonella Enteritidis strains circulating in the non-human population and 
compare these strains to those found in humans. Isolates of poultry origin are of 
great importance to the study, because the association of human infection and 
poultry has been highly described in literature and eggs are still considered the main 
source of human Salmonella Enteritidis infection (Andino and Hanning, 2015). 
Furthermore, the South African government has a zero tolerance for Salmonella 
Enteritidis in poultry and thus theoretically there should not be any Salmonella 
Enteritidis infections in poultry (World poultry, 2016). 
 
However in this study, we observed the presence of Salmonella Enteritidis in poultry. 
This is concerning because it increases the potential spread of this pathogen to 
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humans, therefore leading to potential outbreaks. This needs to be prevented, since 
recovery (economic and food security) from such events could be challenging and 
very costly to the country. Furthermore, in South Africa, chicken and chicken 
derivatives (e.g. eggs) are an important source of protein, since they are cheaper 
compared to other meat products. Thus, reduced control of Salmonella Enteritidis 
would have devastating effects on both consumers and food-producing companies; 
enhanced quality control would drive the price of poultry products up and make it 
unaffordable to minimum wage earners (Cogan and Humphrey, 2003; Hoelzer et al., 
2011; Andino and Hanning, 2015; World poultry, 2016).   
 
4.4.1 MLVA profiles of non-human Salmonella Enteritidis isolates  
 
MLVA profile 28 represented the highest number of isolates; four poultry, one 
environmental, two cheetah and eight of unknown origin. MLVA profile 26 and 35 
were the second and third most common MLVA profiles amongst the non-human 
isolates respectively. Isolates found in both MLVA profiles (MLVA profiles 26 and 35) 
lacked supporting demographic data and therefore were of unknown origin and 
source. MLVA profiles 22, 48, 40 and 41 contained isolates of poultry origin and 
MLVA profile 21 had isolates from poultry and equine origin. Collectively, isolates of 
poultry origin were present in 6/10 MLVA profiles (MLVA profiles 28, 22, 48, 40, 41 
and 21).  Due to lack of added demographic information, we cannot identify whether 
these isolates (poultry) originate for a single geographic region or not. However, the 
data indicates MLVA profile diversity amongst the poultry isolates (Cho et al., 2007). 
In the case of MLVA profiles 28 and 21, the presence of isolates from various origins 
(poultry, equine and cheetah) indicates how widespread MLVA profiles can be, even 
crossing through different animal species. These events are somewhat not surprising 
since these interactions can easily occur in places where different animals live in 
close proximity to one another (i.e. farms). Furthermore, animals such as horses and 
cheetahs can also acquire the infection from the environment, wherein bird and 
poultry faeces may be present. The inclusion of environmental isolates in this study 
emphasizes the role the environment plays in the transmission of disease (Hoelzer 
et al., 2011). 
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Despite the fact that few wild and large domestic animal isolates were received for 
this study, we were still able to observe the presence of Salmonella Enteritidis 
amongst them. More isolates need to be collected, in order to identify the magnitude 
of Salmonella Enteritidis infection within these animal communities.  
 
 
4.5 Non-human Salmonella Enteritidis antimicrobial susceptibility 
profiles 
 
All non-human isolates showed full susceptibility to five of the antimicrobials 
(ampicillin, cotrimoxazole, trimethoprim, tetracycline, and azithromycin). Intermediate 
resistance was observed for ceftriaxone (5%; 2/43) and ciprofloxacin (7%; 3/43). 
Furthermore, 23% (10/43) of the isolates were resistant to sulfamethoxazole. 
 
The number of non-human isolates received in this study was too small to reflect on 
possible antimicrobial patterns. However, we noted low prevalence of intermediate 
resistance for ceftriaxone and ciprofloxacin amongst the isolates received. The 
cause of this intermediate resistance is unknown and many factors may be involved. 
Ceftriaxone and ciprofloxacin are some of the most commonly used antimicrobials in 
the human health. The use of these antimicrobials in food animals for treatment of 
infections has been reported, yet their use in animal prophylaxis is less described as 
compared to the other cephalosporins and fluoroquinolones (Eagar et al., 2012; 
Landers et al., 2012; Moyane et al., 2013). Despite the small numbers of non-human 
isolates received, intermediate resistance to both ceftriaxone and ciprofloxacin is 
concerning. These intermediate resistant strains could potentially spread to humans, 
causing challenges in patient management (Tadesse, 2015). 
 
In this study, sulfamethoxazole resistance amongst non-human isolates (23%; 
10/43) was comparable to that found in human isolates (29%; 348/1221). However, it 
was not possible to establish any connection between the two. Nonetheless, several 
studies have shown evidence of obtaining the same antimicrobial-resistant strain in 
animal produce (e.g. meat and eggs) as that seen to cause clinical infection and 
subclinical colonization in humans (Landers et al., 2012).  
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The use of sulfonamides such as sulfamethoxazole in food animal agriculture for 
growth promotion and prophylaxis has been extensively described in literature from 
various parts of the world. In South Africa, many different classes of antimicrobials 
are used in the food animal industry; these include penicillins, cephalosporins and 
sulfonamides. Eagar et al., (2012), estimated the percentage volume of 
antimicrobials sold in South Africa for water medication between the years 2002-
2004 and sulfonamides were the highest sold antimicrobials accounting for 95.40%, 
second by penicillins (1.80%) and quinolones (1.30%) respectively. Although we 
cannot conclude the main cause for resistance within the non-human isolates, 
supporting literature describes the excessive use of antimicrobials in the food animal 
industry and the role it (excessive use) plays in antimicrobial resistance.  
 
Although sulfamethoxazole, ciprofloxacin and ceftriaxone are used in agriculture, we 
also acknowledge that fact that some of the non-agricultural isolates (equine and 
wild animals) included in this study had (either) intermediate resistance and/or 
antimicrobial resistance to these antimicrobials. Therefore, other factors are involved 
in the emergence of resistance amongst the non-human isolates. Furthermore, we 
do not know the extent at which antimicrobials are being used within the wild animal 
community. These areas need to be explored in order to try establish areas of 
concern and possible interventions of all possible drivers of antimicrobial resistance 
within the animal community. Indeed a larger number of non-human Salmonella 
Enteritidis isolates (from various origins) is necessary in order to achieve this.  
 
 
4.6 Comparison and associations of human and non-human 
Salmonella Enteritidis isolates 
 
The presence of certain MLVA profiles in both humans and non-humans may be 
indicative of transmission between these groups. This was further supported by the 
fact that, MLVA profiles 21, 22 and 28 (predominant amongst human isolates) were 
also present amongst non-human isolates. MLVA profile 28 was the most common 
MLVA profile in both groups (humans and non-humans). However, the reason for 
this predominance is unknown. MLVA profiles 35 and 49 were only present amongst 
non-human isolates. A similar finding was reported by Cho et al., (2008), wherein 
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certain MLVA profiles were only found in animals and not in humans (source specific 
MLVA profiles). However, a larger number of non-human isolates (with known origin 
and source) are necessary in order to confirm their source specific characteristic. 
 
Comparison of MLVA profiles obtained in both human and non-human isolates 
showed that Salmonella Enteritidis strains circulating in both the humans and non-
humans were clonal (i.e. fall under one cluster). However, the number of non-human 
isolates collected, along with the limited geographic data obtained made the 
association of human and non-human isolates challenging. Demographic information 
is vital in the accurate comparison of human and non-human (i.e. animal) infections 
and in the identification of possible transference of disease from animals to humans. 
Data from such studies assist in controlling the spread of zoonotic pathogens such 
as Salmonella Enteritidis in both humans and animals. This is crucial because in 
most animals, Salmonella Enteritidis causes asymptomatic infections, which can 
lead to sporadic outbreaks (Hoelzer et al., 2011). Furthermore, such studies also 
support the need for proper interventions on zoonotic pathogens (Mangni and 
Arvntikis, 2010; Kidanermariam et al., 2010). 
 
 
4.7 Molecular investigation of outbreaks using MLVA 
 
For many years, PFGE has been used as a primary method for molecular subtyping 
of salmonellae; it is still used as a tool for molecular epidemiological investigations 
and outbreak investigations - particularly still used by PulseNet International. 
However, Salmonella Enteritidis has limited heterogeneity (lacks genetic variation), 
thus making discrimination using PFGE challenging. The application of MLVA to a 
wide variety of bacterial species (including Salmonella species) has concluded that 
MLVA is more discriminatory compared to most other available molecular subtyping 
methods, including PFGE. Numerous studies have applied MLVA in the analysis of 
Salmonella Enteritidis in different parts of the world and many studies have applied it 
in outbreak investigations (Hopkins et al., 2011). However, many have remained 
doubtful about the stability of VNTR’s during an outbreak. It is assumed that the 
VNTR’s may evolve rapidly, thereby producing multiple MLVA profiles during an 
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outbreak. A study by Boxrud et al. (2007) analysed the stability of Salmonella 
Enteritidis VNTR’s during an outbreak, they found that the MLVA profiles remained 
stable during the course of the outbreak and a similar finding was observed by 
Malorny et al., (2008).   
 
In this study, we were able to successfully use MLVA as a molecular epidemiological 
tool for the investigation of outbreaks. MLVA was able to group all isolates from one 
outbreak into a single MLVA profile, therefore indicating the stability of the VNTR’s in 
this study. MLVA profile 28 accounted for most of the outbreaks (5/7 outbreaks).  
This MLVA profile had caused outbreaks in four provinces (Mpumalanga, Limpopo, 
Free State and Eastern Cape). This showed that not only is MLVA profile 28 the 
most common MLVA profile in the study (predominantly found in both human and 
non-human isolates), but that it is also able to cause outbreaks throughout the 
country. This is however not surprising, since our data show that it could potentially 
be common within the population and thus the chances of it causing outbreaks 
throughout South Africa is highly plausible. Other predominant MLVA profiles in the 
study were also shown to cause outbreaks. MLVA profile 21 caused an outbreak in 
Gauteng, and MLVA profile 22 caused outbreaks in KwaZulu-Natal and Mpumalanga.  
 
Observation of the MST suggests that MLVA profile 21, 22, and 28 are closely 
related, with a single VNTR locus difference between them (Figure 3.1). This may be 
indicative of shared pathogenicity characteristics between them, which enable them 
to effectively cause outbreaks compared to the other MLVA profiles. WGS analysis 
on these outbreak isolates is necessary in order to identify any shared pathogenicity 
characteristics. However, outbreaks caused by closely related strains (closely related 
MLVA profiles) have been reported.  A study by Slinko et al. (2009) on an outbreak 
of Salmonella Typhimurium, found that outbreaks caused by the STm197 strain had 
produced several closely related MLVA profiles, which had caused outbreaks in 
many restaurants in the city of Brisbane for over two months.  
 
Our findings emphasize the need for analysis of Salmonella Enteritidis isolates from 
different provinces in the country, in order to observe the circulating MLVA profiles in 
each province and their potential to cause outbreaks. 
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4.8  Limitations and future prospects 
 
4.8.1 Limitations 
 
The CED received fewer human isolates from the Western Cape Province in 
comparison to the Gauteng Province. Therefore, the random selection of isolates 
favoured the Gauteng Province (n = 832) more than the Western Cape Province (n = 
389). This gave bias during study population analysis and made any comparison 
between the two provinces challenging. Furthermore, this may have limited our 
chances of obtaining more MLVA profiles from the Western Cape. However, 
statistical analysis did not reveal any significant differences between the two 
provinces and the MLVA profiles obtained in the study showed high clonality 
amongst isolates from both provinces. 
 
Data obtained in this study could not be used to derive an incidence rate. This is 
because the study population was randomly selected from isolates that are obtained 
through the GERMS-SA surveillance programme. Such data does not give a true 
reflection of the burden of Salmonella Enteritidis in South Africa, since most people 
with less severe disease do not seek health care, and those who do often receive 
empiric therapy during consultation and a stool specimen is rarely taken. However, 
this aspect was not the primary focus of the study and thus it did not have an effect 
on the ability to identify Salmonella Enteritidis strain diversity in South Africa. 
 
The non-human isolates received, as well as the demographic data that 
accompanied the isolates were extremely limited. Data was sometimes even 
completely non-existent. This was despite our continuous appeals and requests for 
isolates from the sending laboratories. This made linking of human and non-human 
Salmonella Enteritidis infection a difficult task. 
 
In this study, reference strains were not used to normalize raw fragment data to 
actual fragment sizes. This was because no reference strains had been validated for 
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Salmonella Enteritidis MLVA at the time of the study.  This made inter-laboratory 
comparison of the MLVA data impossible. However, Peters et al. (2017) published 
the first list of validated reference strains for Salmonella Enteritidis MLVA. This will 
be beneficial for future Salmonella Enteritidis MLVA studies. 
 
4.8.2 Future prospects  
 
Although clonality of Salmonella Enteritidis strains was presumed through analysis of 
the MST, further analysis of the MLVA profiles using WGS is necessary. This is 
because MLVA only looks at a small segment of the genome and mutations in any of 
the five VNTR’s may affect its credibility. WGS analysis on the other hand analyses 
the pathogen’s whole genome and it can identify strain diversity using other 
sequence variations such as SNPs. WGS analysis has become the ultimate tool, it is 
gradually becoming more accessible to all and will eventually replace all current 
subtyping methods. 
  
Studies associating human and non-human (e.g. food animals) Salmonella 
Enteritidis infection are necessary within South Africa. Furthermore, studies with 
large numbers of non-human (i.e. animal) isolates are necessary to conclude 
definitive infection transference between humans and animals.  
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CHAPTER 5: CONCLUSIONS 
 
 
Of the 1221 human Salmonella Enteritidis isolates (389 from Western Cape and 832 
from Gauteng) were included in the study, a high number of cases was noted 
amongst the <1-4 years and 34-44 years age groups. The high number of isolates 
amongst the <1-4 years age group could be attributed to an immature immune 
system and the high number of isolates amongst the 34-44 years age group may be 
attributed to the HIV epidemic within the country. Invasive isolates accounted for 
34% of the total isolates. We noted that invasive disease was prominent amongst the 
young children (<4 years), the elderly and the adult age groups (HIV infected 
population age groups). The main cause of invasive disease could not be 
established.  However, poor immune function could be playing a role in susceptibility 
to invasive disease.   
 
A total of 43 non-human isolates were included in the study. Such few non-human 
isolates were included in the study, because obtaining non-human isolates from 
veterinary laboratories was challenging. The veterinary laboratories were unwilling to 
provide isolates or further details about the isolates due to loyalty towards their 
customers. This led to the receiving of 21 (49%) isolates with absolutely no 
supporting data, including origin and source. However, the rest of the isolates were 
of avian, equine, poultry, environmental (animal environment) and wild animal origin. 
 
This study represented the first ever-molecular subtyping analysis of large number of 
Salmonella Enteritidis isolates in any African country using MLVA. A total of 86 
MLVA profiles were obtained from 1264 isolates (1221 human isolates and 43 non-
human isolates). MLVA was able to successfully distinguish Salmonella Enteritidis 
strains that differed by one VNTR locus. MLVA also demonstrated the clonality of 
Salmonella Enteritidis strains circulating amongst the human and non-human 
isolates, because the MLVA profiles obtained in the study had a maximum of two 
VNTR loci differences. Therefore, a single cluster was obtained in the study.  
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Of the 86 MLVA profiles identified, four predominant MLVA profiles (MLVA profiles 7, 
21, 22 and 28) were obtained amongst the human isolates. MLVA profile 28 was the 
most common MLVA profile throughout the study (2013-2015) and the exact cause 
for this was unknown. MLVA profiles 28, 21 and 22 were predominantly present in 
the Gauteng province and MLVA profile 7 was predominantly present in the Western 
Cape.  
 
A total of 10 MLVA profiles were obtained from 43 non-human isolates. As found in 
the human isolates, MLVA profile 28 was the most predominant MLVA profile. Thus, 
indicating possible dominance within both populations. Isolates of poultry origin were 
present in a number of MLVA profiles (MLVA profiles 28, 22, 48, 40, 41 and 21). This 
suggests MLVA profile diversity amongst poultry isolates. However, more non-
human isolates are necessary to identify the extent of Salmonella Enteritidis infection 
within the non-human population. Furthermore, 8/10 MLVA profiles were present in 
both human and non-human isolates. MLVA profiles 35 and 49 were only found 
amongst non-human isolates. However, more non-human isolates need to be 
analysed to conclude their source specificity.   
 
A total of 348 (29%) human isolates were resistant to sulfamethoxazole. The cause 
of such resistance could not be established, however sulfamethoxazole resistance 
within the Salmonella Enteritidis isolates could be due to excessive (i.e. prophylactic) 
use. Furthermore, the excessive use of sulfamethoxazole in the agricultural sector 
could also be a key role player in sulfamethoxazole resistance. A similar finding was 
observed amongst the non-human isolates, with sulfamethoxazole resistance at 23% 
(n = 10), thus emphasizing that the excessive use of antimicrobials in the agricultural 
sector plays a role in the emergence of antimicrobial-resistant isolates. 
 
During the years 2013-2015, seven Salmonella Enteritidis outbreaks were 
investigated from six provinces. Isolates from each individual outbreak showed an 
identical MLVA profile, thus showing VNTR stability. Three MLVA profiles were 
obtained (MLVA profiles 21, 22 and 28) and MLVA profile 28 accounted for most of 
the outbreaks (5/7 outbreaks), thus showing its ability to spread throughout the 
country. Observation of the MST showed that MLVA profile 21, 22, and 28 are 
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closely related, with a single VNTR locus difference between them. This may be 
indicative of shared pathogenicity mechanisms between them. 
 
Finally, in this study MLVA has shown to be a successful molecular subtyping tool for 
Salmonella Enteritidis, for both surveillance purposes and outbreak investigations. 
MLVA is a relatively inexpensive, easy and consistent molecular typing method. In 
this study we showed that VNTR’s can be stable during an outbreak, making MLVA 
a quicker way of discriminating outbreak strains from non-outbreak strains. We 
observed that Salmonella Enteritidis strains circulating within the Western Cape and 
Gauteng Province were very clonal and that such clonality may be an indication of 
the bigger picture occurring throughout the country. We also observed that 
Salmonella Enteritidis strains circulating in both the human and non-human 
populations were clonal, which may be indicative of active transmission between the 
two. The prevalence of antimicrobial resistance amongst all isolates was low 
although sulfamethoxazole resistance was notable. Emphasis needs to be placed in 
curbing the spread of Salmonella Enteritidis amongst the young, the immune-
compromised individuals and the elderly, since they are more at risk of infection by 
invasive and antimicrobial-resistant Salmonella Enteritidis. This study also showed 
the need for more emphasis on the one health approach; both human and animal 
health sectors have to work together to curb the spread of zoonotic diseases within 
the country. In association with the current epidemiological surveillance programs, 
studies such as this can provide valuable information for the development of public 
health strategies to minimize or control the risk of outbreaks and epidemics by 
Salmonella Enteritidis. 
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APPENDICES 
 
Appendix A: Site of Salmonella Enteritidis isolation 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Abscess aspirate 
Blood 
Bone marrow 
Cerebral spinal fluid 
Stool 
Pleural fluid 
Pus 
Pus swab 
Sputum 
Superficial swab 
Tissue 
Urine 
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Appendix B: Preparation of TE buffer 
 
TE buffer (10mM Tris, 1mM EDTA pH 8.0) 
10 ml of 1M Tris* (pH 8.0) 
2 ml of 0.5M EDTA* (pH 8.0) 
Dilute to 1000 ml with sterile water and autoclave. 
Reagent manufacturer: *Tris (Merck, Darmstadt, Germany); *EDTA (Sigma Aldrich, St Louis, 
USA) 
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Appendix C: Real-time PCR for Salmonella 
 
Table. Primer and probe sequences used to amplify the target genes for Salmonella species, Salmonella Typhimurium and 
Salmonella Enteritidis (Malorny et al., 2004; O'Regan et al., 2008; Park et al., 2008). 
 
*PCR product size: bp- base pair. 
 
Target 
organism 
Target 
gene 
PCR 
primer/probe 
Primer/probe sequence *PCR 
product size 
Manufacturer  
      
Salmonella 
species 
ttrRSBCA ttr-6 (forward) CTCACCAGGAGATTACAACATGG 95 bp Inqaba  
(Pretoria, SA) 
  ttr-4 (reverse) AGCTCAGACCAAAAGTGACCATC  Inqaba  
( Pretoria, SA) 
  ttr-5 probe 
(Salmonella) 
6FAM - CACCGACGGCGAGACCGACTTT - 
BHQ1 
 Roche  
(Johannesburg, SA) 
      
Salmonella 
Typhimurium 
STM4497 STM-F1 GCGCACCTCAACATCTTTC  62 bp Inqaba  
( Pretoria, SA) 
  STM-R1 CGGTCAAATAACCCACGTTCA  Inqaba  
( Pretoria, SA) 
  STM-probe1 NED - ATCATCGTCGACATGC - MGBNFQ  Life Technologies  
( Johannesburg, SA) 
      
Salmonella 
Enteritidis 
sdf SES-F1 AAATGTGTTTTATCTGATGCAAGAGG  299 bp Inqaba  
( Pretoria, SA) 
  SES-R1 GTTCGTTCTTCTGGTACTTACGATGAC  Inqaba  
( Pretoria, SA) 
  SES-probe2 Cy5 - 
CGAATGGTGAGCAGACAACAGGCTGATTTA - 
BBQ 
 Roche  
(Johannesburg, SA) 
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Primers and probe re-suspension 
 
Primers and probes are received as lyophilized products and are re-suspended with 
TE buffer at pH 8.0, according to the manufacturer’s instructions to make a 100µM 
stock solution. The primer/probe mix for Salmonella species, Salmonella 
Typhimurium and Salmonella Enteritidis real-time PCR reaction was prepared by 
adding the stock solutions into a 1.5 ml tube as outlined in the Table below. The mix 
is then stored at -20°C. 
 
Table. Primer/probe mix for Salmonella species, Salmonella Typhimurium and 
Salmonella Enteritidis real-time PCR reaction.  
 
Preparation of Salmonella species, Salmonella Typhimurium and Salmonella 
Enteritidis real-time PCR reaction 
Preparation of the real-time PCR involves the adding of all reagents outlined on the 
below table, in each reaction well. Since DNA is not added in the non-template 
control (NTC) well, autoclaved deionized water is added in substitution.  
Table. Reagents and reagent volumes included in the Salmonella real-time PCR 
reaction. 
Reagents Volume (µl) Manufacturers 
Primer/probe mix 3 - 
Invitrogen Express real-time PCR 
supermix universal 
25 Life technologies 
(Carlsbad, USA) 
Autoclaved deionized water 20 - 
Crude DNA 2 - 
Total 50  
PCR targets Contents  Volume 
 PCR/molecular grade water 45 µl 
Salmonella genus ttr-6 (forward) primer 21 µl of 100 µM 
ttr-4 (reverse) primer 21 µl of 100 µM 
ttr-5 probe 4 µl of 100 µM 
Salmonella Typhimurium STM-F1 primer 48 µl of 100 µM 
STM-R1 primer 48 µl of 100 µM 
STM-probe1 9 µl of 100 µM 
Salmonella Enteritidis SES-F1 primer 93 µl of 100 µM 
SES-R1 primer 93 µl of 100 µM 
SES-probe2 18 µl of 100 µM 
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Appendix D: MLVA 
 
Table. Primer sequences used to amplify the five VNTR loci for Salmonella Enteritidis (Hopkins et al., 2011) 
Target gene 
locus 
PCR primer Primer sequence (5' to 3') Expected fragment 
sizes (base pair) 
VNTR repeat length 
(base pair) 
Manufacturer 
      
SENTR7 SENTR7-F 6FAM-ACGATCACCACGGTCACTTC 
 
117-135 9 Life Technologies  
(Johannesburg, SA) 
 SENTR7-R CGGATAACAACAGGACGCTTC 
 
  Inqaba  
( Pretoria, SA) 
      
SENTR5 SENTR5-F 6FAM-CACCGCACAATCAGTGGAAC 
 
235-301 6 Life Technologies  
(Johannesburg, SA) 
 SENTR5-R GCGTTGAATATCGGCAGCATG 
 
  Inqaba  
( Pretoria, SA) 
      
SENTR6 SENTR6-F NED-ATGGACGGAGGCGATAGAC 
 
173-236 7 Life Technologies  
(Johannesburg, SA) 
 SENTR6-R AGCTTCACAATTTGCGTATTCG 
 
  Inqaba  
( Pretoria, SA) 
      
SENTR4 SENTR4-F VIC-GACCAACACTCTATGAACCAATG 
 
112-147 7 Life Technologies  
(Johannesburg, SA) 
 SENTR4-R ACCAGGCAACTATTCGCTATC 
 
  Inqaba  
( Pretoria, SA) 
      
SE-3 SE-3-F VIC-CAACAAAACAACAGCAGCAT 
 
308-320 12 Life Technologies  
(Johannesburg, SA) 
 SE-3-R GGGAAACGGTAATCAGAAAGT 
 
  Inqaba  
( Pretoria, SA) 
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Primers and probe re-suspension 
 
Primers and probes are received as lyophilized products and are re-suspended with 
TE buffer at pH 8.0, according to the manufacturer’s instructions to make a 100µM 
stock solution. The forward primer and reverse primer mix for the Salmonella MLVA 
PCR reaction was prepared by adding the forward and reverse stock solutions into 
separate 1.5 ml tubes as outlined below. The mix is then stored at -20°C. 
 
Primer mix - forward primers (primer mix made on amber-coloured tubes) 
 
65 µl of deionized autoclaved water 
7 µl of SENTR7-F  primer (10 μM) 
7 µl of SENTR5-F  primer (10 μM) 
7 µl of SENTR6-F  primer (10 μM) 
7 µl of SENTR4-F  primer (10 μM) 
7 µl of SE-3-F primer (10 μM) 
 
 
Primer mix - reverse primers (primer mix made on clear tubes) 
 
65 µl of deionized autoclaved water 
7 µl of SENTR7-R  primer (10 μM) 
7 µl of SENTR5-R  primer (10 μM) 
7 µl of SENTR6-R  primer (10 μM) 
7 µl of SENTR4-R  primer (10 μM) 
7 µl of SE-3-R primer (10 μM) 
 
 
Preparation of Salmonella Enteritidis MLVA PCR 
 
 
Table. Reagents and reagent volumes included in the Salmonella Enteritidis MLVA 
PCR. 
 
 
 
Reagents Volume (µl) Manufacturers 
Autoclaved deionized water 7.5 - 
Qiagen master mix 12.5 Qiagen ( Hilden, Germany) 
Qiagen Q-solution 2.5 Qiagen ( Hilden, Germany) 
Forward primer 1 - 
Reverse primer 1 - 
Crude DNA  1 - 
Total 25  
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Table: Summary of the 86 MLVA profiles along with their VNTR allele size numbers 
MLVA Profile number SENTR7 SENTR5 SENTR6 SENTR4 SE-3 
1 132 268 177 112 318 
2 132 268 219 112 318 
3 132 280 184 112 318 
4 132 280 177 119 318 
5 132 280 184 112 306 
6 132 280 177 112 306 
7 132 280 177 119 306 
8 132 280 184 119 306 
9 132 244 170 112 306 
10 123 262 177 126 306 
11 123 250 212 140 306 
12 123 226 212 126 306 
13 123 226 205 133 0 
14 123 226 205 133 318 
15 123 226 191 0 306 
16 123 274 184 126 318 
17 123 226 184 0 318 
18 123 262 191 112 318 
19 123 274 0 112 318 
20 123 262 0 112 318 
21 123 274 184 112 318 
22 123 262 184 112 318 
23 123 280 184 112 318 
24 123 244 184 112 318 
25 123 286 184 112 318 
26 123 268 191 112 318 
27 123 268 0 112 318 
28 123 268 184 112 318 
29 123 268 177 112 306 
30 123 268 184 119 306 
31 123 268 184 112 306 
32 123 226 212 126 0 
33 123 262 191 119 306 
34 123 262 177 119 306 
35 123 208 219 119 306 
36 123 280 177 119 306 
37 123 274 184 119 306 
38 132 268 0 119 306 
39 132 274 0 119 306 
40 132 274 177 119 306 
41 132 286 177 119 306 
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42 132 268 177 119 306 
43 132 256 177 119 306 
44 132 208 177 119 306 
45 132 292 177 119 306 
46 132 238 184 119 306 
47 123 250 219 140 306 
48 123 268 177 119 306 
49 123 280 191 112 318 
50 123 268 219 140 306 
51 132 268 184 112 318 
52 123 280 177 112 318 
53 123 274 177 112 318 
54 123 268 177 112 318 
55 123 268 184 119 318 
56 123 262 205 119 306 
57 123 262 184 119 306 
58 123 280 177 119 318 
59 132 268 184 119 306 
60 114 226 212 126 0 
61 114 268 184 112 318 
62 114 280 177 112 306 
63 123 274 219 119 306 
64 123 244 170 119 306 
65 132 286 177 112 306 
66 123 286 177 119 306 
67 123 286 177 112 306 
68 132 286 177 119 318 
69 123 226 191 133 306 
70 123 262 191 133 306 
71 123 280 177 126 306 
72 132 268 184 119 318 
73 132 262 184 119 306 
74 123 292 177 112 306 
75 123 256 198 119 306 
76 123 256 177 112 318 
77 132 274 184 112 318 
78 123 262 177 112 318 
79 123 268 212 140 306 
80 123 244 212 140 306 
81 123 268 226 140 306 
82 132 280 177 126 306 
83 123 268 163 133 306 
84 123 250 212 133 306 
85 132 262 177 119 306 
86 123 268 219 126 306 
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Appendix E: Information of Salmonella Enteritidis outbreaks 
 
 
Outbreak 1: 
Outbreak 1 occurred in the KwaZulu- Natal Province during May 2013. Two people 
were affected, due to the consumption of liver of a dead goat. The goat was reported 
to have had diarrhoea prior to its death. Three isolates were received (two human 
isolates and one goat meat isolate). All isolates belonged to MLVA profile 22 
(123_262_184_112_318). 
Outbreak 2: 
Outbreak 2 occurred in the Mpumalanga Province in November 2013. The outbreak 
was associated with food poisoning. However, no further details were provided about 
the outbreak. Three human isolates were received from the outbreak. All isolates 
belonged to MLVA profile 22 (123_262_184_112_318). 
Outbreak 3: 
Outbreak 3 occurred in the Limpopo Province in January 2014. This foodborne 
outbreak occurred in a lodge. Sixty-five people were affected, eight of whom were 
admitted to hospital in critical condition. Further investigation of the food showed 
Salmonella contamination. Three human isolates were received from the outbreak. 
All isolates belonged to MLVA profile 28 (123_268_184_112_318). 
Outbreak 4: 
Outbreak 4 occurred in the Mpumalanga Province in July 2014. The outbreak was 
associated with food prepared for a funeral. Forty-six people were affected, six of 
whom were children who were admitted to hospital in critical condition. Fourteen 
human isolates were received from the outbreak. All isolates belonged to MLVA 
profile 28 (123_268_184_112_318). 
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Outbreak 5: 
Outbreak 5 occurred in the Free State Province in November 2014. The outbreak 
was associated with food prepared for a function in a mine. Eighty people were 
affected, six of whom were hospitalized. Three human isolates were received from 
the outbreak. All isolates belonged to MLVA profile 28(123_268_184_112_318). 
Outbreak 6: 
Outbreak 6 occurred in the Eastern Cape Province in December 2014. The outbreak 
occurred in a TB hospital. However, no further details were provided about the 
outbreak. Ten human isolates were received from the outbreak. All isolates belonged 
to MLVA profile 28 (123_268_184_112_318).  
Outbreak 7: 
Outbreak 7 occurred in the Gauteng Province in October 2015. The outbreak was in 
a private residence, where chicken feet were cooked by a mother for dinner. Four 
children were affected (age 4, 7, 8 and 11). Three human isolates were received 
from the outbreak. All isolates belonged to MLVA profile 21 
(123_274_184_112_318). 
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